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ABSTRACT 
This works explores the use of rhodium-catalyzed intramolecular C–H insertion 
on diazosulfones and sulfonates as a tool to simplify the synthesis of organic molecules. 
Dirhodium-induced intramolecular C–H insertion on diazo carbonyl compounds is a 
relatively well-studied reaction. It occurs with an overwhelming bias for the formation of 
five-membered carbocycles or heterocycles, with the order of reactivity of C–H bonds 
being methine > methylene >> methyl. This intrinsic preference can be overridden by 
dissimilar factors such as substrate conformation, insertion site electronic effects and the 
reactivity of the dirhodium catalyst.  
This study has disclosed that when diazo- sulfones and sulfonates are employed, 
dirhodium-induced intramolecular C–H insertion preferentially forms six-membered 
heterocycles. Apparently, the difference in bond lengths and bond angles around the SO2 
fragment incorporated into the newly forming ring allows more distant C–H bonds to be 
targeted for insertion. The preference for formation of six- versus five-membered 
heterocyclic sulfones, however, is tenuous in nature, and is dependent on the substrate 
structure and the nature of the dirhodium catalyst used. Dirhodium catalysts bearing 
electron poor ligands shift the preference back to formation of five-membered rings, 
presumably due to forming more reactive carbenoid intermediates. The presence of 
methyl substituents on the carbon atom adjacent to the sulfone fragment also favors the 
formation of five-membered sulfones, likely due to the steric compression of the bond 
angle. Rh2(S-pttl)4 [dirhodium(II)tetrakis(N-phthaloyl-(S)-tert-leucinate)] catalyst has
 
 
xxix 
 
been identified as the current best lead to the development of chiral catalysts for this 
reaction. Selectivity of 3:1 (50% ee) was achieved with its use, and 20:1 (91% de) when 
combined with the use of a (-)-menthol-based chiral auxiliary.  
 The synthetic utility of these novel six-membered heterocycles has also been 
explored.  To which end, the enantioselective synthesis of bakuchiol has been achieved in 
14 linear steps by employing intramolecular C–H insertion on a diazo sulfonate to install 
the quaternary center in its structure. The alkylation of these substrates with active 
electrophiles under relatively mild conditions and with excellent yields has been attained 
with high diastereoselectivity. Novel methodologies have been originated to transform 
the obtained δ-sultones into γ-butyrolactones and δ-valerolactones using TBHP/t-BuOK 
and SmI2/DMPU, respectively. The conversion of carbethoxythiane-1,1-dioxides to 
cyclic α-sulfonyl oximes has also been demonstrated under relatively mild conditions 
(NaH, isoamyl nitrite, rt, 8 h).  Currently, the versatility of these new transformations is 
being pursued in the synthesis of the natural products quebrachamine and mesembrine. 
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CHAPTER 1 
 GENERAL INTRODUCTION AND BACKGROUND 
1.1 C–H Bond Functionalization via Carbon–Carbon Bond Formation 
 In 2011, the FDA approved thirty five new drugs that offered significant advances 
in the treatment of hepatitis C, lupus, late-stage prostate cancer, pneumonia and other 
life-threatening diseases.
1
 Most of these drugs were small molecule (molecular weight 
less than 1000) organic compounds. Increased knowledge about the in vivo activity of 
these drugs will lead to the development of analogs and other new drugs, which at times 
is associated with increase in molecular complexity. The development of these drugs 
entails complex and lengthy multi-step syntheses, which are often reflected in the cost of 
production, availability, marketing price, and overall success of the drug. This increases 
the need to develop efficient synthetic strategies that would allow the synthesis of 
bioactive molecules in an economical fashion. 
 Over the years, the synthesis of organic molecules has been achieved by 
modifying precursors and intermediates at preexisting functional groups.
2-5
 This 
conventional approach neglects sp
3
 carbon–hydrogen (C–H) bonds, which are ubiquitous 
in organic molecules and are usually the most prevalent “functional group”.6-9 The sp3 C–
H bond has a bond length of 1.09 Å, bond energy of 413 kJ/mol, and it is non-polar 
because of a small difference in electronegativity between carbon and hydrogen.
9, 10
 In 
general, the sp
3
 C–H bond is inert. The inertness arises from the fact it possesses no 
 2 
 
empty orbitals of low energy or filled orbitals of high energy that can readily participate 
in a chemical reaction.
6, 11
 The inertness and ubiquitous nature of sp
3
 C–H bonds makes 
the development of synthetically useful reactions daunting. However, the advent of 
efficient selective C–H bond functionalization strategies, especially in the context of 
carbon–carbon (C–C) bond formation, could greatly improve the available methods for 
making organic molecules.
12-14
 A major challenge to the development of such strategies 
has been the need for reagents that are reactive enough to cleave the relatively stable C–H 
bonds but still sufficiently selective to distinguish between the different types of C–H 
bonds in organic molecules.
15-22
 
 In organic substrates, the functional groups present dictate the reactivity of 
proximal C–H bonds. This notion has been used to classify C–H bonds on organic 
substrates into three groups: sp
2
 hybridized C–H bonds, activated sp3 hybridized C–H 
bonds, and unactivated sp
3
 hybridized C–H bonds (Figure 1).5 C–H bonds which are sp2 
hybidized are found in arenes and alkenes, while activated sp
3
 C–H bonds refer to sp3 C–
H bonds adjacent to heteroatoms or functional groups. Unactivated sp
3
 C–H bonds, on 
the other hand, are not adjacent to a heteroatom or functional group. Activated sp
3
 
hybridized C–H bonds are weaker (and thus more reactive) than their unactivated 
counterparts and can be selectively functionalized.
5, 6, 8, 23-28
 The selective activation of 
sp
3
 hybridized C–H bonds is known to be both kinetically and thermodynamically 
unfavorable. Nevertheless, huge strides have been made in recent years to selectively 
activate these bonds thanks to the works of Smoliakova,
29, 30
 Sames,
5
 and Murai.
31
  
 3 
 
 
 
Figure 1. Different types of C–H bonds in organic substrates; FG represents other 
functional groups in the substrates.
5
 
 
 
 Historically, the functionalization of C–H bonds via C–C bond formation heavily 
depended on radical reactions.
32, 33
 However, the ubiquity of C–H bonds in organic 
substrates and the difficulties associated with controlling radical reactions significantly 
retarded the development of efficient and synthetically meaningful transformations. Over 
the past three decades, considerable progress has been made in the area of C–H bond 
functionalization.
5, 6, 14, 34
 Two cutting edge transition-metal-based transformations have 
been originated for C–H bond functionalization, specifically with respect to new C–C 
bond formation. 
 The first of these transformations is direct C–H activation, which entails adding a 
reactive transition metal complex (Ru, Ir, Rh or Pd) across a relatively strong C–H bond 
(90-105 kcal/mol) to form a weaker carbon–metal bond (50-80 kcal/mol), followed by a 
subsequent transformation to generate a new C–C bond (Scheme 1).29, 35-37  Direct C–H 
activation owes its roots to the pioneering work of Shilov,
38
 Bercaw,
6
 Bergman,
25
 
Crabtree,
39, 40
 Murai
31
 and Goldman,
41
 and dates back to the 1970s and 1980s. 
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Scheme 1. Direct C–H activation mechanism; “R” represents a nucleophile and MLn 
represents reactive transition metal complex.
34
 
 
 
 Direct C–H activation generally involves harsh reaction conditions (high 
temperatures), which may not be tolerated by other functional groups on the substrate. 
This, alongside the fact that the reactive transition metal complex may bind too tightly 
with the C–H bond, has limited the use of this transformation for synthetic purposes.6, 37, 
42
 An attempted solution to this problem has been the use of neighboring functional 
groups to direct less reactive metal complexes to the target C–H bond activation site.11, 25, 
43
 Less reactive metal complexes tend to bind loosely and generate activated C–H bonds, 
which are more reactive and, thereby, creating more avenues for subsequent 
transformations. 
 For some time, direct C–H activation has been restricted to sp2 hybridized C–H 
bonds (aryl and vinyl), since the activation of sp
3
 hybridized C–H bonds is known to be 
unfavorable, both kinetically and thermodynamically. In recent years, Murai and co-
workers have taken advantage of the fact sp
3
 hybridized C–H bonds adjacent to 
heteroatoms are weaker (more reactive) to show that pyrrolidine and piperidine C–H 
bonds can be activated by Ru3(CO)12 and further coupled to unactivated alkenes.
44
 In the 
aforementioned transformation, the 2-pyridyl nitrogen atom on compound 4 is needed to 
 5 
 
direct the ruthenium complex to the desired C–H bond resulting in the formation of 
ruthenium hydride complex 6, which reacts with the unactivated alkene 7 to form alkyl 
ruthenium complex 8, from which reductive elimination gives the final product 9 
(Scheme 2). 
 
 
Scheme 2. Proposed mechanism for direct C–H bond activation of activated sp3 C–H 
bonds using ruthenium complexes by Murai et al.
44
 
 
 
Expanding on Murai’s work, Sames and co-workers have developed the arylation 
of sp
3
 hybridized C–H bonds without the aid of a directing group.28, 43 They demonstrated 
that N-phenylpyrrolidine can be arylated with iodobenzene in the presence of Cs2CO3 and 
t-BuOH (Table 1). Mechanistic investigations revealed an oxidative pathway for the 
reaction. Even though these results reveal that sp
3
 hybridized C–H bonds can be directly 
activated, the yields for the products remain relatively low, considerably limiting the 
synthetic utility of this transformation. 
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Table 1. Studies on non-directed sp
3
 C–H bond activation using ruthenium complexes 
reported by Sames et al.
28
 
 
 
 
 
The other type of transition-metal-based transformations for functionalizing C–H 
bonds is metal-carbenoid C–H insertion. In this case, the reactive transition metal 
complex inserts into a C–H bond to generate a three-centered cyclic transition state, 
which leads directly to the functionalized products (Scheme 3).
3, 45-51
 Unlike C–H 
activation, metal carbenoid C–H insertion is highly selective. The metal complexes, 
which initiate the reaction, are readily regenerated rendering the process highly catalytic. 
The metal carbenoids are masked carbenes, and require an appropriate level of 
electrophilicity to proficiently effect C–H insertion. If the metal carbenoid is extensively 
electrophilic, competing side reactions become an issue.
4, 34
 On the other hand, if the 
 7 
 
electrophilicity is insufficient, the metal carbenoid lacks the reactivity to insert into an 
unactivated C–H bond.  
 
 
Scheme 3. Catalytic cycle for C–H functionalization by metal carbenoid insertion from 
diazo compounds.
34
 
 
 
Free carbenes are overly reactive and tend to react with organic substrates in 
ways, which are unselective and uncontrollable.
52-54
 The binding of the metal complex to 
the carbene serves to modulate its reactivity, thereby allowing more control over the 
outcome of the reaction. The metal complex binds to the carbene through strong σ-
acceptor interactions and weak Π-back donation interactions, which stabilize the carbine, 
but still ensure that it remains active enough to insert into a C–H bond.14, 55 Overall, the 
reactivity of the carbenoid is determined by the nature of the ligands on the metal 
complex as well as the substituents adjacent to the carbene moiety. 
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1.2 Classes of Metal Carbenoid 
In general, metal carbenoids are conveniently obtained by the extrusion of 
nitrogen from diazo compounds.
56
 Depending on the substituents adjacent to the diazo 
moiety, three classes of metal carbenoids have been distinguished: acceptor carbenoids, 
acceptor/acceptor carbenoids, and donor/acceptor carbenoids (Figure 2).
3
 In this context, 
acceptor refers to an electron-withdrawing group (EWG) while donor refers to an 
electron-donating group (EDG). Typical acceptor groups are carbonyl, nitro, cyano, 
phosphonyl and sulfonyl, while typical donor groups are vinyl, aryl and heteroaryl. The 
presence of an EWG increases the electrophilicity and reactivity of the resulting 
carbenoid, while that of an EDG stabilizes the carbenoid and enhances its selectivity.
15, 57-
59
 
 
 
Figure 2. Classes of diazo-based metal carbenoids.
34
 
 
 Acceptor carbenoids are highly reactive but exhibit limited selectivity since they 
do not bear an EDG. The high reactivity makes them susceptible to competing reactions 
like carbene dimerization. Acceptor carbenoids are commonly used in intramolecular and 
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cyclopropanation reactions, in which their reactivity can be modulated by steric effects.
17, 
60
 
Acceptor/acceptor carbenoids are obtained from diazo compounds bearing two 
EWGs. The presence of the second EWG stabilizes the diazo compounds, and highly 
reactive metal catalysts are needed for the extrusion of nitrogen to form the carbenoids. 
Once formed, the resulting carbenoids are highly reactive and are liable to carbene 
dimerization. Acceptor/acceptor carbenoids can also be used for intramolecular and 
cyclopropanation reactions, even though they will be less selective than their acceptor 
counterparts.
17, 61
    
Donor/acceptor carbenoids are derived from diazo compounds that possess an 
EWG and a donor substituent like a vinyl or aryl group, capable of stabilizing the 
resulting carbenoid through resonance.
49, 60
 Again, because the diazo precursor is 
stabilized, very reactive metal catalysts are needed to generate the carbenoid. This class 
of carbenoids exhibits high chemoselectivity and is widely used for intermolecular 
reactions.  
 
1.3 Use of Rhodium(II) Complexes in Carbenoid C–H Insertion 
Rhodium(II) complexes are the most effective and versatile catalysts for metal 
carbenoid-mediated C–H insertion.20, 62-67 Prior to the introduction of rhodium(II) 
complexes by Teyssie and co-workers in the 1980s, mostly copper complexes were 
employed with varying levels of success.
63, 68, 69
 The superiority of rhodium(II) 
complexes lies in its inherent ability to form Rh–Rh bonds. This intrinsic property 
 10 
 
permits the formation of a dirhodium-bridge, caged within a ‘lantern’ structure, which is 
thought to be the essential feature of these complexes.
57, 70, 71
 Only one of the two 
rhodium atoms actually binds to the carbene; the other atom serves as an electron sink to 
increase the electrophilicity of the carbenoid moiety, and also facilitates the cleavage of 
the rhodium–carbon bond upon completion of the reaction.15, 55 To date, four main classes 
of rhodium(II) complexes have been established for metal carbenoid insertion reactions. 
They are rhodium(II) carboxylates, rhodium(II) carboxamidates, rhodium(II) phosphates, 
and ortho-metalated arylphosphine rhodium(II) complexes. More recently, rhodium(II) 
carboxylates and carboxamidates have emerged at the forefront as the most effective and 
versatile catalysts for carbenoid C–H insertion.46, 47, 72 Representative examples include: 
Rh2(OAc)4 (rhodium acetate) 14, Rh2(S-DOSP)4 (tetrakis[(S)-(+)-N-(p-
dodecylphenylsulfonyl)prolinato]dirhodium(II) 15, Rh2(S-pttl)4 (dirhodium(II) tetrakis[N-
phthaloyl-(S)-tert-leucinate]) 16, Rh2(S-MEPY)4 (dirhodium(I1) tetrakis[methyl-2-
pyrrolidone-5(S)-carboxylate]) 17 among others. The reactivity of these rhodium(II) 
complexes is governed by the nature of the ligands on the dirhodium bridge.
55, 57
 In 
general, electron-withdrawing ligands tend to increase the electrophilicity and reactivity 
of the catalyst, while electron-donating groups tend to enhance the selectivity. 
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Figure 3. Common rhodium catalysts used for carbenoid C–H insertion of diazo 
compounds.
14
 
 
1.4 Rhodium-Catalyzed C–H Insertion Mechanism 
The catalytic cycle of rhodium-catalyzed C–H insertion reactions involves three 
main steps: (1) rhodium-assisted nitrogen extrusion from the diazo compound, (2) 
activation of the C–H bond and (3) C–C bond formation.55, 61, 73 The sequence of 
occurrence of the C–H activation and C–C bond formation steps has been a subject of 
considerable speculation and various models of the C–H activation transition state (TS) 
have been proposed. Doyle and co-workers based on experimental results put forth a 
model, in which after nitrogen extrusion, there is overlap of the carbenoid’s p-orbital with 
the σ-orbital of the reacting C–H bond to form a three-centered concerted transition state 
where C–C and C–H bond formation with the carbene carbon occurs at the same time as 
the ligated metal dissociates but not to the same extent (Scheme 4).
15
 They further 
emphasized that the presence of electron-withdrawing ligands on the dirhodium bridge 
increases the elcetrophilicity of the carbene and forces bond formation to occur at a 
greater distance, resulting in an early transition state, which leads to lower selectivity. On 
the other hand, the presence of electron-donating ligands favors a late transition state and 
leads to higher selectivity.   
 12 
 
 
 
Scheme 4. Proposed mechanistic pathway by Doyle et al. for rhodium-catalyzed C–H 
insertion from diazo precursors.
15
 
 
 
 Taber and co-workers suggested a four-centered transition state whereby there is 
an interaction between the hydrogen of the C–H bond and one of the rhodium atoms 
(Scheme 5).
21, 74
 According to this model, after nitrogen extrusion, the resulting carbenoid 
20 can be depicted as an inverted ylide 21, which rapidly forms a reversible three-
centered two electron intermediate complex 22. For bond formation to proceed, a four-
centered TS 23 is needed, in which the Rh–C bond is aligned with the target C–H bond. 
Provided sufficient overlap exists, the electron pair of the C–H bond moves to form a 
new C–C bond, and synchronously, the electron pair of the Rh–C bond moves to form a 
new C–H bond. This affords product 24 and releases initial rhodium complex 14.  
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Scheme 5. Proposed mechanism by Taber et al. for rhodium-catalyzed C–H insertion 
from diazo precursors.
21
 
 
 
A recent demonstration by Nakamura and co-workers confirmed the model 
advanced by Doyle and co-workers.
55
 Using B3LYP density functional studies on 
dirhodium tetracarboxylate-catalyzed C–H bond activation, they disclosed the energetics 
and geometry of important intermediates and TS in the catalytic cycle. They proposed 
that the reaction is initiated by the formation of a complex between the rhodium catalyst 
and the diazo compound. This is followed by back donation of electrons from the 
rhodium 4dxz orbital to the C–N σ*-orbital, which provides the driving force for nitrogen 
extrusion to form the rhodium carbenoid. 
The rhodium carbenoid is highly electrophilic because of its vacant 2p orbital. As 
such, the C–H activation and formation of the C–C bond proceed in a single step via a 
three-centered hydride transfer-like TS with small activation energy. Throughout the 
reaction, only one of the two rhodium atoms serves as a carbene binding site; the other 
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assists the C–H insertion reaction by enhancing the electrophilicity of the carbene bound 
rhodium and facilitating the cleavage of the rhodium–carbon bond. Neither of the 
rhodium atoms interacts directly with the target C–H bond undergoing insertion. 
 
Scheme 6. Proposed mechanism by Nakamura et al. for rhodium-catalyzed C–H insertion 
from diazo precursors.
55
 
 
 
1.5 Synthetic Utility of Rhodium-Induced C–H Insertion 
Rhodium-induced C–H insertion can either be intermolecular or intramolecular.58, 
75-78
 For some time, regioselectivity challenges associated with intermolecular substrates 
and competing side reactions, like carbene dimerization, limited rhodium carbeonid C–H 
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insertion to substrates capable of intramolecular reactions; whereby the target C–H bond 
and the rhodium carbenoid are connected by a suitable tether, which provides close 
proximity leading to favorable regioselectivities.
42
 However, vigorous research in the 
area of intermolecular rhodium-catalyzed C–H insertion has shown that this 
transformation is just as strategic and meaningful synthetically as the intramolecular 
version.
19, 49, 75, 76, 79
 
 
1.5.1 Intermolecular Rhodium-Induced C–H Insertion 
The disclosure by Davies and co-workers that donor/acceptor carbenoids are 
capable of undergoing highly regio- and stereoselective intermolecular C–H insertion 
reactions has evolved intermolecular C–H insertion from a synthetically limited reaction 
to a broadly useful transformation.
19, 49, 75
 This is highlighted by a number of impressive 
examples, in which intermolecular C–H insertion has been employed as a strategic 
reaction to install stereogenic centers in natural product targets.
3, 49, 77
  
Intermolecular C–H insertion is best catalyzed by Rh2(S-DOSP)4 and is highly 
favored at sites that stabilize positive charge.
19, 80
 It can occur at primary, secondary and 
tertiary C–H bonds, controlled by a tenuous balance of steric and electronic factors. 
Based on the ability of the substrate to stabilize positive charge, the trend of reactivity is 
as follows: tertiary > secondary > primary. However, because the rhodium(II) catalyst 
bears bulky ligands, from a steric stand point, the order of reactivity becomes primary > 
secondary > tertiary. Overall, secondary C–H bonds are most favored because they 
stabilize positive charge without being too sterically crowded. 
67, 81
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Intermolecular C–H insertion reactions can be separated into cyclopropanation,82 
[4 +3] cycloaddition
50
 and C–H functionalization.83 Intermolecular cyclopropanation 
routinely occurs with high diasteroselectivity (>20 : 1 dr), and the obtained 
cyclopropanes can be rearranged or ring-opened to allow the synthesis of other organic 
compounds. An illustrative example is the reaction of styryldiazoacetate 32 with styrene 
33 catalyzed by Rh2(S-DOSP)4 to afford vinylcyclopropane 34 in 79% yield, > 20 : 1 dr 
and 98% ee.
84
 The resulting vinylcyclopropane 34 has been converted to amino acids 35 
and 36, and cyclopropanedicarboxylate 37, which can be ring-expanded when subjected 
to Lewis acid-catalyzed conditions in the presence of an aldehyde or ring-opened by a 
cuprate reagent, as illustrated in the synthesis of the antidepressant (+)-sertraline 38 by 
Corey and coworkers.
82
 
 
 
Scheme 7. Rhodium-catalyzed intermolecular cyclopropanation in the synthesis of the 
antidepressant (+)-sertraline by Corey et al.
82
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A representative example of an intermolecular [4+3] cycloaddition is that between 
vinyldiazoacetate 39 and the (E,Z)-diene 40 catalyzed by Rh2(OOct)4 to generate 
cycloheptadiene 42 as a single regioisomer and diastereomer in 49%.
85
 Selective 
intermolecular cyclopropanation of the (Z) double bond occurs to generate the 
divinylcyclopropane 41, which undergoes a Cope rearrangement to provide 42 as a single 
diastereomer. The cis double bond of 42 is reduced by Wilkinson’s catalyst to form 43. 
Base hydrolysis of the acetyl group followed by in situ lactonization results in the 
synthesis of (±)-tremulenolide A 44. Also, DIBAL reduction of the two esters on 43 
completes the synthesis of (±)-tremulenediol 45. 
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Scheme 8. Rhodium-catalyzed intermolecular [4 + 3] cycloaddition in the synthesis of 
(±)-tremulenolide A and (±)-tremulenediol by Davies and co-workers.
85
 
 
 
When some chiral catalysts are used in intermolecular [4 + 3] cycloaddition, the 
directing ability of a chiral substrate can be overridden. This has been demonstrated by 
Sarpong and co-workers
86
 in a parallel kinetic resolution approach used to synthesize 
cyathane and cyanthiwigin diterpenes. The Rh2(S-DOSP)4-catalyzed reaction of (+)-46 
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preferentially favors the formation of 48, while that of (-)-46 leads to 50. Compound 48 is 
a precursor to (-)-cyanthiwigin G 49, while 50 is a precursor to (+)-cyanthin A3 51. 
 
 
Scheme 9. Synthesis of cyathane and cyanthiwigin diterpenes via intermolecular 
rhodium-catalyzed C–H insertion.86 
 
Intermolecular C–H insertion reactions can also provide complementary 
approaches to conventional synthetic strategies to help streamline the preparation of 
target natural products. For instance, intermolecular C–H insertion adjacent to oxygen 
forms β-hydroxy esters, which are products routinely derived from aldol reactions,87 
similarly, the same reaction on analogous leads to β-amino esters, products of a Mannich 
reaction (Scheme 10).
88
 In Scheme 10a, intermolecular insertion is preferentially favored 
at the C–H bond adjacent to the siloxy group of compound 52 rather than the acetoxy 
group. This stems from the fact that the electron-withdrawing acetoxy group deactivates 
the adjacent C–H bonds towards insertion, while the electron-donating siloxy group 
 20 
 
activates the adjacent C–H bonds towards insertion. In Scheme 10b, the benzylic C–H 
bonds in compound 57, which are electronically most activated, are sterically 
inaccessible so the insertion occurs at the methyl C–H bonds. 
 
 
Scheme 10. Intermolecular rhodium-catalyzed insertion applied to the synthesis of 
products classically obtained by aldol and Mannich reactions.
87, 88
  
 
 
The synthesis of the antidepressant (S)-venlafaxine by Davies and co-workers is 
an impressive example where this chemistry has been put to use.
89
 In the synthesis, 
Rh2(S-DOSP)4-catalyzed reaction of aryldiazoacetate 62  with N-methyl-1-aza-2,5-
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disilacyclopentane 63, generated β-amino ester 64 in 68% yield and 93% ee, which was 
further converted in two steps to (S)-venlafaxine 65 (Scheme 11). The disilyl protecting 
group in 63 serves to protect the amino group from the electrophilic carbenoid, so that 
just its adjacent C–H bonds can react in an intermolecular fashion with the carbenoid. 
Also, the disilyl group is very labile, and the β-amino ester is readily released and 
isolated as its hydrochloride salt. 
 
 
Scheme 11. Intermolecular rhodium-catalyzed C–H insertion applied to the synthesis of a 
β-amino ester en route to the synthesis of (S)-venlafaxine.89 
 
 
Intermolecular C–H insertion reactions are also capable of initiating cascade 
reactions.
90-92
 An elegant example of this class of reactions has been termed the combined 
C–H activation/Cope rearrangement.92 The reaction occurs in a concerted fashion through 
a six-membered transition state to form products that are normally obtained from 
intermolecular C–H insertion followed by a Cope rearrangement. However, the 
intermolecular C–H insertion product was reported not to be an intermediate in this 
reaction because it is the most stable thermodynamic product. The pathway is thought to 
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be initiated by intermolecular insertion, but is interrupted by Cope rearrangement leading 
to the formation of product 69 (Scheme 11). 
 
 
Scheme 12. Mechanistic pathway for the combined C–H activation/Cope 
rearrangement.
92
 
 
The combined C–H activation/Cope rearrangement has been employed as as the 
key step in the synthesis of the diterpenes (-)-colombiasin A and (-)-elisapterosin B, both 
isolated from Pseudopterogorgia elisabethae (Scheme 13).
93
 In the synthesis, 
dihydronapthalene 70 and vinyldiazoacetate 71 undergo a combined C–H 
activation/Cope rearrangement catalyzed by Rh2(R-DOSP)4 to  form products 72 and 73. 
Apparently, when the reaction is catalyzed by Rh2(R-DOSP)4, one enantiomer of 
dihydronapthalene undergoes combined C–H activation/Cope rearrangement to provide 
72, while the other enantiomer is converted by cyclopropanation to 73. Compound 72 is 
obtained in 41% yield, with 92% ee. In the reaction, three chiral centers common to both 
natural products are obtained. Compound 72 is then transformed in seven and eight steps 
to (-)-colombiasin A 74 and (-)-elisapterosin B 75, respectively.  
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Scheme 13. Combined C–H activation/Cope rearrangement applied to the synthesis of (-
)-colombiasin A and (-)-elisapterosin B.
93
 
 
 
Several pharmaceutical agents have been synthesized by applying 
enantioselective intermolecular C–H functionalization as a critical step in the syntheses. 
(+)-Cetiedil 79,
94
 (S)-venlafaxine 65,
89
 ritalin 82
95
 and (+)-indatraline 85
96
 are some 
representative examples among others. In the synthesis of (+)-cetiedil (Scheme 14), 
thiophenyldiazoacetate 76 undergoes an allylic C–H insertion with 1,4 cyclohexadiene 77 
catalyzed by Rh2(R-DOSP)4 to form 78 in 57% yield and 88% ee. Chloride 78 is further 
converted in two steps to furnish the cholinesterase inhibitor (+)-cetiedil 79.  
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Scheme 14. Intermolecular rhodium-catalyzed C–H insertion applied to the synthesis of 
(+)-cetiedil.
94
  
 
 Ritalin, also known as (+)-methylphenidate, is used for the treatment of attention 
deficit hyperactivity disorder (ADHD). Conventional synthetic approaches to this 
compound involve multi-step synthesis; conversely, intermolecular rhodium-catalyzed 
C–H insertion allowed a direct and rapid approach. The Rh2(S-biDOSP)4-catalyzed 
reaction of the protected piperidine 80 with methyl phenyldiazoaceatate 81, followed by 
removal of the protecting group, completed a rapid synthesis of (+)-methylphenidate 82 
(Scheme 15). 
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Scheme 15. Intermolecular rhodium-catalyzed insertion applied to the synthesis of (+)-
methylphenidate.
95
 
 
 Indatraline is a potent psychoactive compound with a strong binding and 
inhibitory affinity for monoamine reuptake inhibitors such as dopamine and serotonin. 
The synthesis of indatraline has been completed via Rh2(S-DOSP)4-catalyzed reaction of 
(3,4 dichlorophenyl)diazoacetate 83 and 1,4-cyclohexadiene 77 to give C–H insertion 
product 84 in 83% yield and 93% ee. Product 84 was then transformed in six steps to (+)-
indatraline 85 (Scheme 16). 
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Scheme 16. Intermolecular rhodium-catalyzed insertion applied to the synthesis of (+)-
indatraline.
96
 
 
1.5.2 Intramolecular Rhodium-Induced C–H Insertion 
The majority of synthetically meaningful rhodium(II) catalyzed reactions are 
intramolecular C–H insertion reactions.97-102 As mention earlier, this occurs when the 
rhodium carbenoid and the target C–H bond are in the same molecule, connected by a 
suitable tether. In general, rhodium-induced intramolecular C–H insertions are best 
catalyzed by rhodium(II) carboxamidates
103
 and  occur with an overwhelming preference 
for the formation of five-membered carbocyles/hetereocycles, in which the order of 
reactivity is tertiary > secondary >> primary.
45, 104
 This inherent preference can be 
overridden by substrate conformation, local electronic effects and the nature of the 
ligands on the rhodium catalyst to obtain four- and six-membered ring compounds on 
select substrates.
57, 70
 However, there is no standard procedure that dictates the 
application of these controlling factors. At times, competing influences may result in the 
formation of mixtures of products as demonstrated by Hu and co-workers in the β- and γ- 
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lactam synthesis via C–H insertion of diazoacetamides (Scheme 17).105 The activating 
effect of the amide nitrogen and the strong electron-withdrawing substituent attached to 
the carbene favored the formation of a β-lactam. Apparently, the presence of the strong 
electron-withdrawing substituent leads to the early TS 88 resulting in β-lactam 90. The 
absence of a strong electron-withdrawing substituent favored a late TS 89 leading to γ-
lactam 91. 
 
 
Scheme 17. Formation of β- and γ-lactams by intramolecular rhodium-catalyzed 
insertion.
105
 
 
A notable feature of intramolecular C–H insertion is its inherent ability to convert 
an acyclic tertiary chiral center into a cyclic quaternary chiral center with retention of 
absolute configuration.
74, 106
 This phenomenon has been exploited by Taber and co-
workers in the synthesis of (-)-hamigeran B (Scheme 18).
106
 A key step in the synthesis 
was the Rh2(S-pttl)4-catalyzed reaction of α-aryl-α-diazoketone 92, which leads to the C–
H insertion product 93 in 83% yield with retention of configuration at the quaternary 
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center. However, a mixture of diastereomers was obtained because of the sterogenic 
center adjacent to the carbonyl moiety. The desired configuration was conveniently 
attained by equilibrating the mixture, and subsequent steps furnished the product (-)-
hamigeran B 94. 
 
 
Scheme 18. Intramolecular rhodium-catalyzed insertion applied to the synthesis of (-)-
hamigeran B.
106
 
 
  During intramolecular C–H insertion, EDG and heteroatoms tend to activate 
adjacent C–H bonds towards insertion, while EWG deactivate adjacent C–H bonds.107, 108 
This aspect of intramolecular C–H insertion has been utilized by Fukuyama and co-
workers to generate benzofurans from α-aryl-α-diazoketones via intramolecular C–H 
insertion en route to the synthesis of the complex macrocyclic spermine alkaloid (-)-
ephedradine (Scheme 19).
107
 In one case, reaction of α-aryl-α-diazoketone 95 catalyzed 
by Rh2(S-DOSP)4  led to  C–H insertion product 96 in 63% yield. A diastereomeric ratio 
of 13 : 1 was obtained with the aid of a chiral auxiliary in combination with the chiral 
catalyst. Benzofuran 96 was converted to the product (-)-ephedradine 97 in 14 steps.  
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Scheme 19. Intramolecular rhodium-catalyzed insertion applied to the synthesis of (-)-
ephedraline.
107
 
 
Intramolecular C–H insertion has been widely used in the synthesis of γ-
butyrolactones and γ-lactams (Scheme 20).108, 109 Notable examples are the 
pharmaceutical agents (R)-baclofen
.
HCl 101 and (R)-rolipram 105, respectively. (R)-
Baclofen
.
HCl is a GABAB receptor agonist, while (R)-rolipram is a phosphodiesterase 
type IV inhibitor. The synthesis of 101 begins from p-chlorophenethyl alcohol and 
involves a Rh2(S-MPPIM)4-catalyzed intramolecular C–H insertion reaction of 
diazoacetate 99 to afford the γ-butyrolactone 100 in 81% yield and 99% ee, which is 
further converted to 101 in a 60% overall yield.
110
 Hu and co-workers
111
 have reported 
the synthesis of 105 starting from isovanillin 102 and utilizing cumyl(2,2-dimethyl-
benzyl) as an N-protecting group for a Rh2(MEOX)4-catalyzed intramolecular C–H 
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insertion of α-diazoacetamide 103 to provide the γ-lactams 104 in 64% yield and 46% ee. 
Removal of the cumyl protecting group furnishes 105 in 15% overall yield. 
 
 
Scheme 20. Synthesis of γ-butyrolactones and γ-lactams by intramolecular rhodium-
catalyzed insertion.
110, 111
 
 
Naturally occurring lignin lactones such as (±)-enterolactone 106, (±)-hinokinin 
107, (-)-arctigenin 108, (+)-isodeoxy-podophyllotoxin 109, (+)-isolauricerisinol 110, and 
(+)-imperanene 111, are some representative examples of natural products that have been 
synthesized by employing intramolecular C–H insertion to generate γ-butyrolactones as 
crucial steps in the syntheses (Figure 4).
112
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Figure 4. Natural occurring lignin lactones synthesized by using rhodium-catalyzed 
intramolecular C–H insertion to generate γ-butyrolactones.112 
 
 
Another important aspect of intramolecular C–H insertion is that the reaction can 
break the symmetry of molecules, thereby generating complex products from relatively 
simple precursors. This aspect has been put into use by Taber and co-workers in the 
synthesis of the sesquiterpene antibiotic pentalenolactone E.
113
 In a key step of the 
synthetic route (Scheme 21), the tricyclic ketone 114 is furnished by Rh2(OAc)4-
catalyzed intramolecular C–H insertion of α-diazo-β-ketoester 113 with a single chiral 
center. The ester is converted to tricyclic ketone 114 with high asymmetric induction 
resulting in three chiral centers. The tricyclic ketone is then converted in five steps to 
complete the synthesis of pentalenolactone E 115. 
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Scheme 21. Use of intramolecular rhodium-catalyzed insertion in the synthesis of 
pentalenolactone E by Taber and co-workers.
113
 
 
 
The effectiveness of rhodium-catalyzed intramolecular C–H insertion to form new 
C–C bonds in fused-ring systems under strained conditions has also been 
demonstrated.
114, 115
 In the synthesis of (+)-morphine by White et al. (Scheme 22),
114
 
carboxylic acid 116 was treated with oxalyl chloride followed by diazomethane to form 
α-diazoketone 117 in 63% yield. Rh2(OAc)4-catalyzed intramolecular insertion of 117 
afforded the fused-cyclopentanone 118 in 50% yield, from which the piperidine ring of 
(+)-morphine 119 was installed at a later stage in the synthesis. 
 
Scheme 22. Use of intramolecular rhodium-catalyzed insertion to construct carbocycles 
in strained and fused systems.
114
 
 
Similarly to the synthesis of (+)-morphine, Srikrishna and Gharpure
115
 have 
reported the synthesis of (-)-neopupukean-4,10-dione 122, (-)-neopupukean-10-one 123, 
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(-)-2-pupukeanone 129 and (-)-4-thiocyanatoneopupukeanane 125. A characteristic 
feature of neopupukeananes is the presence of the subtle 9-isopropyl-3,6-
dimethyltricyclo[4.3.1.0]decane (isotwistane) framework that constitutes two quaternary 
carbon atoms in addition to the isocyano and thiocyanato moieties. In the report, the 
isotwistane framework was formed via Rh2(OAc)4-catalyzed intramolecular insertion 
from the corresponding diazo ketone 121. The diazo ketone is obtained from (R)-carvone 
120 by employing double Michael reactions with LiHMDS and methyl methacrylate to 
get bicyclic keto esters, which are further subjected to base hydrolysis to get the 
corresponding keto acids. Treatment of the keto acids with oxalyl chloride followed by 
diazomethane results in the formation of the desired diazo ketones. The isotwistane 
framework is then converted to the various neopupukeananes by subsequent reactions.  
 
 
Scheme 23. Synthesis of neopupukeananes via intramolecular rhodium-catalyzed 
insertion.
115
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Using similar transformations to the ones described above, the synthesis of (-)-2-
pupukeanone was also completed starting from 120 (Scheme 24). Rh2(tfa)4-catalyzed 
intramolecular C–H insertion of the diazo ketone 127gave diketone 128 in 47% yield, 
which was converted in three steps to (-)-2-pupukeanone 129. 
 
 
Scheme 24. Synthesis of (-)-2-pupukeanone via intramolecular rhodium-catalyzed 
insertion.
115
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CHAPTER 2 
 RHODIUM-CATALYZED INTRAMOLECULAR C–H INSERTION ON 
DIAZOSULFONES AND DIAZOSULFONATES 
2.1 Introduction 
 The earliest studies on rhodium-catalyzed intramolecular C–H insertion on α-
diazosulfones were performed by Durst and co-workers.
116, 117
 These studies 
demonstrated the formation of five-membered γ-sulfones fused to phenyl, thiophene and 
indole ring compounds (Table 2). The products are formed from the insertion of the 
rhodium carbenoid carbon into an aromatic ortho C–H bond. However, the reaction 
shows a preference to products arising from insertion at the carbon atom para to alkoxy 
substituents in cases where competition between para- and ortho C–H bonds is possible 
(substrate 133, Table 2). Also, ortho-methoxy substituted aromatic α-diazosulfones 
provide no identifiable products (substrate 134, Table 2), perhaps due to competing 
oxygen ylide formation, followed by decomposition. The presence of an additional 
substituent adjacent to the sulfone fragment (substrate 135, Table 2) result in the 
formation of diasteromers, but with no influence on the outcome of the reaction. While it 
is possible to obtain products with α-diazo esters, α-diazo ketones and sulfonyl 
diazomethane afford no products under the same reaction conditions. Following this 
initial report by Durst and co-workers, for over two decades, there have been no other 
reports on either intermolecular or intramolecular C–H insertion involving α-
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diazosulfones and α-diazosulfonates, in which the sulfone fragment is a part of the 
formed ring. 
 
Table 2. Rhodium-catalyzed intramolecular C–H insertion resulting in the formation of γ-
sulfones fused to phenyl, thiophene and indole ring compounds reported by Durst and co-
workers.
116
 
 
S Ar P Yield (%) 
 
130  
 
 
14-48 
 
131   
 
50 
 
132 
  
 
24 
 
133  
 
 
42 
 
134 
  
 
0 
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Table 2. Cont.    
S Ar P Yield (%) 
 
135 
 
 
 
47 
 
 
Recently, Du Bois and co-workers have demonstrated that rhodium nitrenoids 
generated from the corresponding sulfamate esters undergo intramolecular nitrogen–
hydrogen insertion to form six-membered ring sulfamates.
118-121
 As proposed, the 
difference in bond lengths and bond angles around the sulfur atom is responsible for the 
change of preference. Expanding on Du Bois’ work, Novikov and co-workers previously 
disclosed the preferential formation of cyclic six-membered sulfones and sulfonates via 
rhodium-catalyzed intramolecular C–H insertion of aliphatic diazosulfones and 
diazosulfonates (Table 3).
122
 As in the case of nitrene insertion, the preference for six-
membered rings has also been attributed to longer bond lengths and larger bond angles 
around the sulfonyl fragment incorporated into the newly forming ring, which allows 
more distant C–H bonds to be targeted for insertion resulting in favorable six-membered 
ring.  
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Table 3. Rhodium-catalyzed intramolecular C–H insertion of aliphatic diazosulfones and 
diazosulfonates leading to the formation of six-membered rings by Novikov and co-
workers.
122
 
 
S X R P Yield (%) 
 
 
136 
 
CH2 
 
 
 
55
a
 
 
137 
 
CH2  
 
 
56 
 
138 
 
O  
 
 
53 
 
139 
 
O  
 
 
55
a
 
 
140 
 
O 
 
 
 
80
b
 
 
a
 Isolated as a single isomer. 
b
 Diasteromeric ratio varied from experiment to experiment, ranging from complete to 
2:1 in favor of the same diasteromer 
 
 
A subsequent report by Wolckenhauer et al.
123
 has shown that in the case of 
diazosulfonates, the preference for six-membered rings persists on a variety of substrates 
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(Table 4). Remarkably, the preference for six-membered rings is maintained even when 
formation of a strained system is required. 
 
Table 4. Formation of six-membered sulfonates from the corresponding diazosulfonates 
via intramolecular rhodium-catalyzed C–H insertion reported by Wolckenhauer and co-
workers.  
 
S R P Yield (%) 
 
141 
 
 
 
84
b
 
 
142 
 
 
 
94
a
 
 
143 
 
 
 
85
a
 
 
144 
 
 
 
64
a
 
 
145  
 
 
57
c 
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Table 4. Cont.    
S R P Yield (%) 
 
146 
 
 
 
66
d
 
 
147 
 
 
 
68
a
 
 
148 
 
 
 
77
a
 
 
a
: Rh2(OAc)4, DCM; 
b
: Rh2(esp)2, DCM; 
c
: Rh2(tpa)4, DCM; 
d
: Rh2(tfa)4, CCl4 
 
2.2 Formation of Five- versus Six-Membered Cyclic Sulfones via Rhodium-Catalyzed 
Intramolecular C–H Insertion 
 
 In the initial report by Novikov and co-workers in 2007,
122
 sulfone 149a (Table 5) 
was identified as the major product of intramolecular C–H insertion of the corresponding 
diazosulfone 136. A more detailed analysis of the reaction mixture revealed the presence 
of a small amount of the cis isomer as well as isomers with a five-membered ring. This 
provoked follow-up studies into the contributing roles of the catalyst, structure of the 
diazosulfone, and the local C–H insertion site electronic effects to the selectivity of the 
reaction.
124
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 An effort to characterize the reaction mixture proved daunting as the separation 
of the other isomers (five-membered ring isomers and the cis six-membered ring isomer) 
turned out to be difficult, and was further complicated by simultaneous equilibrium 
between 150a and 150b during flash chromatography. However, it was found that the 
mixture of 150a and 150b isomerized with DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) in 
DCM (dichloromethane) for 24 h at room temperature to provide exclusively 150a. Also, 
equilibrating the mixture prior to flash chromatography separation simplified the 
purification of the products. Curiously, under these isomerization conditions, the six-
membered ring diastereomers 149a and 149b formed a mixture with a ratio close to 1:1. 
 Mindful of the fact that the electronic properties of the ligands on the rhodium 
catalyst dictate the reactivity of the resultant rhodium carbenoid, the efficacy of other 
catalysts in the reactions of the diazosulfone substrate 136 was investigated (Table 5). 
Doyle’s Rh2(cap)4 (rhodium(II) caprolactam),
125
 which is known to enhance C–H 
insertion selectivity, Rh2(tpa)4 ( rhodium(II) triphenyl acetate), and Du Bois’
118
 tethered 
Rh2(esp)4  (bis[rhodium(α, α, ά, ά -tetramethyl-1,3-benzenedipropionic acid)]) catalysts 
proved effective for this transformation showing results similar to Rh2(OAc)4. Rh2(cap)4 
catalyst was unreactive at room temperature or at reflux in DCM, necessitating a switch 
to the higher boiling solvent dichloroethane. Unexpectedly, Rh2(pfb)4 (rhodium(II) 
perfluorobutyrate) catalyst led to a reversal of the usual selectivity, providing exclusively 
the five-membered ring products. These results infer that rhodium(II) catalysts with 
strong electron-withdrawing ligands such as Rh2(pfb)4 tend to favor the formation of five-
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membered sulfones, while those with electron-donating ligands tend to favor six-
membered sulfones.
124
 
 
Table 5. Effect of catalyst on five- versus six-membered sulfone selectivity reported by 
Jungong et al.
124
 
 
Rh2L4, conditions
a
 Yield of 149
b
 (%) Yield of 150
b
 (%) 
Rh2(OAc)4, rt, DCM 65 9 
Rh2(esp)2, rt, DCM 70 9 
Rh2(tpa)4, rt, DCM 50 20 
Rh2(cap)4, 80 
o
C, (CH2Cl)2 60 8 
Rh2(pfb)4, rt, DCM 27 49 
 
a
 All reactions were carried out by slow addition of the solution of diazosulfone to 1 
mol% of the catalyst. 
b
 Isolated yields, combined for both diastereomers 
 
 
 In order to explore the effect of the structure of the diazosulfone and that of the 
C–H insertion site on the selectivity of the transformation, the necessary diazosulfone 
substrates were prepared using the synthetic sequence outlined in Scheme 25. The 
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appropriate alkyl bromide or alkyl tosylate was subjected to a nucleophilic substitution 
reaction by ethyl mercaptoacetate in the presence of potassium carbonate and catalytic 
amounts of sodium iodide in refluxing acetone. For diazosulfone 153 (Scheme 25), the 
solvent was switched to DMF (dimethylformamide). The resulting sulfides were oxidized 
to sulfones using m-CPBA (meta-chloroperoxybenzoic acid) in DCM or oxone in a 1:1 
mixture of acetone and water. The obtained sulfones were then treated with NosN3 (4-
nitrobenzenesulfonyl azide) in the presence of DIPEA (diisopropylethylamine) in CH3CN 
(acetonitrile) or DMF to afford the desired diazosulfones. Preparation of diazosulfone 
154 was achieved by acid-catalyzed SN1 substitution to make the sulfide which was 
further converted to the corresponding diazosulfone as described above.  
 
 
Scheme 25. Preparation of diazosulfones.
124
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 As mentioned in the previous chapter, intramolecular C–H insertion is favored at 
sites that stabilize positive charge. Decrease in substitution at the C–H insertion site 
(substrate 155, Table 6) predictably disfavored the insertion, resulting in the preferential 
formation of the five-membered ring products, with only small amounts of the six-
membered ring sulfone. This stems from the fact that secondary C–H bonds stabilize 
positive charge better than primary C–H bonds, and as such, insertion is favored at the 
secondary C–H bond leading to the formation of the five-membered ring sulfone, while 
that at the less favored primary C–H bond results in the six-membered sulfone. 
Remarkably, the use of Rh2(pfb)4, which at this point in the study was known to favor 
five-membered ring sulfones, made the preference for five-membered ring sulfones 
complete, also greatly improving the yield of the product. No trace amounts of six-
membered sulfone were detected.  
 
Table 6. Effects of structure of diazosulfone on selectivity of rhodium-catalyzed 
intramolecular C–H insertion leading to the formation of five- and six-membered rings 
reported by Jungong et al.
124
  
 
S R1 R2 R3 conditions
a
 Yield of P.1
b
 (%) Yield of P.2
b
 (%) 
136 H H Me A 65 9 
155 H H H A 2 25 
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Table 6. Cont. 
 R1 R2 R3 conditions
a
 Yield of P.1
b
 (%) Yield of P.2
b
 (%) 
155 H H H B 4 45 
155 H H H C Not detected 80 
156 Me H Me A 40             24  
156 Me H Me B 26 34 
156 Me H Me C 8 60 
157 Me Me Me D 5 75 
157 Me Me Me E Not detected 64 
 
a
 Conditions: A: Rh2(OAc)4, DCM, rt; B: Rh2(esp)2, DCM, rt; C: Rh2(pfb)4, DCM, rt; D: 
Rh2(OAc)4, (CH2Cl)2, reflux; E: Rh2(pfb)4, (CH2Cl)2, reflux. 
b
 Isolated yields, combined for both diastereomers 
 
 
 The presence of substituents adjacent to the sulfone moiety favored the formation 
of five-membered ring sulfones. Monomethyl substitution (substrate 156, Table 6) led to 
the formation of almost equivalent amounts of five- and six-membered sulfones. Use of 
Rh2(pfb)4 enhanced the shift in selectivity; making the five-membered ring sulfone the 
prevalent product. Notably, selectivity in the formation of the substitution center adjacent 
to the sulfone fragment (β-position) was observed for this substrate.  
The formation of small amounts (5-10% combined) of several products possibly 
containing the opposite configuration at the β-position was observed. Definitive 
identification of these products was not achieved due to the difficulty encountered during 
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purification. The dimethyl-substituted diazosulfone 157 was stable to the rhodium 
catalysts screened at rt or reflux in DCM, requiring reflux in dichloroethane to react. The 
reaction resulted in the formation of a five-membered ring even with Rh2(OAc)4. Use of 
Rh2(pfb)4 led to complete selectivity towards the five-membered sulfone at the expense of 
decreased yield. These results can be explained by the decrease in the angle of C–C–SO2 
fragment due to steric compression, favoring the five-membered ring geometry.  
Having established that the structure of the diazosulfone, local insertion site 
electronic effects, and rhodium catalyst used affect the selectivity of the reaction, the next 
objective was to investigate the feasibility of formation of four-membered sulfones. The 
necessary substrates (Table 7) were prepared as described previously. 
 
 
Table 7. Preparation of diazosulfones. 
 
S R S.1 S.2 Yield (%) 
158  
 
 
88 
159 
  
 
85 
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Table 7. Cont. 
S R S.1 S.2 Yield (%) 
160 
 
 
 
90 
 
 
 
Surprisingly, Rh2(pfb)4 reacted with diazosulfone 158.S.2 to form exclusively 
five-membered ring. Even though Rh2(pfb)4 is known to favor the formation of five-
membered ring, C–H insertion was expected to occur at the secondary C–H bond due to 
its ability to stabilize positive charge better, which would lead to the formation of a four-
membered ring. When Rh2(OAc)4 was used, decomposition of the diazosulfone was 
observed with no traces of a sulfone product. Increasing substitution at the secondary 
insertion site (diazosulfone 159.S.2), Rh2(pfb)4  reacted to form a four-membered sulfone. 
The obtained four-membered sulfone was stable enough to be fully characterized, but 
gradually isomerized via elimination to alkenylsulfone 161 (Scheme 26).  
 
 
Scheme 26. Isomerization of a four-membered ring sulfone to an alkenylsulfone. 
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As expected, the insertion was favored at the tertiary C–H bond over the primary 
C–H bond of diazosulfone. Again, use of Rh2(OAc)4 resulted in complete decomposition 
of the diazosulfone with no isolatable products. Reaction of Rh2(pfb)4 with diazosulfone 
160.S.2, which possesses  primary, secondary and tertiary insertion sites, furnished a 
five-membered ring sulfone.  
 
 
Table 8. Studies on the formation of four-membered ring sulfones. 
 
S R1 R2 R3 method Yield of P.1 (%) Yield of P.2 (%) 
158.2 H H H A Not detected 67 
158.2 H H H B Not detected Not detected 
159.2 Me H H A 57
a
 Not detected 
159.2 Me H H B Not detected Not detected 
160.2 H Me Me A Not detected 52 
 
A: Rh2(pfb)4, DCM, rt; B: Rh2(OAc)4, DCM, rt 
a
 Reported yield is for four-membered sulfone, which isomerized over time to 
alkenylsulfone 161. 
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2.3 Structural and Stereochemical Assignments of the Products 
The relative stereochemistry of the products was determined by employing 
standard NMR techniques (
1
H, 
13
C{
1
H}, COSY, DEPT, and NOE). The relative 
configuration of stereocenters in 149a was assigned on basis of the coupling constants 
between Hb and Hc (Figure 5). Smaller coupling constant and appearance of another 
coupling constant to Ha (confirmed by COSY) indicate the equatorial position of Hb. 
Similarly, diaxial arrangement of Hb and Hc is established in 156.1, while indicating the 
cis arrangement in 156.2. Bidirectional NOE correlation between Ha and Hb established 
the configuration of the β-center. While formation of the cis isomer of 157.1 appeared to 
occur in the reaction of 157 (by presence of characteristic peaks in the crude spectra), it 
appeared to recede after equilibration, and only 157.1 was isolated. It has been verified 
that 157.1 does not change upon treatment with DBU, unlike 149a and 156.1, which 
produce mixtures of cis and trans isomers. This could be explained by unfavorable diaxial 
interaction with the methyl group that would be present in the cis isomer of 157.1, but not 
in 149b and 156.2. 
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Figure 5. Stereochemical and structural assigments of the six-membered sulfones.
124
 
 
All five-membered products were isolated as single isomers after equilibration. 
They all show similar patterns of chemical shifts and NOE correlations between protons. 
The five-membered ring products have been assigned trans configuration for the Me, Et, 
and CO2Et substituents on the basis of NOE data and coupling constants. Observed NOEs 
and their relative intensities were consistent with the proposed structures, while several 
disagreements can be found with the cis isomers. Additionally, the large coupling 
constant (10 Hz) between Hc and He in 150a (Hc and He in 155.2, Hd and Hh in 156.2, Hc 
and Hf in 157.2) indicate a dihedral angle that is close to either 0 or 180° (Figure 6). 
Weak NOE correlations between these hydrogens suggest against the small dihedral 
angle that would force these hydrogens to a close proximity. For 156.2, relative 
configuration of the C5 center was unambiguously confirmed by a bidirectional NOE 
between Hb and Hd. 
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Figure 6. NOE responses (%) observed for isomers 150a, 155.2, 156.2, and 157.2.
124
 
 
 
2.4 Conclusion 
Intramolecular rhodium-catalyzed C–H insertion on alkylsulfonyl diazoacetate 
substrates initially reported to favor six-membered ring compounds is sensitive to the 
structure of the substrate as well as the catalyst used. The presence of substituents 
adjacent to the sulfonyl moiety was found to tilt the selectivity of the transformation 
towards the formation of five-membered sulfones. Unexpectedly, the same influence was 
exerted by Rh2(pfb)4 catalyst, apparently due to the presence of the strong electron-
withdrawing ligands, which led to increased activity. This work has highlighted the fact 
that the selectivity of intramolecular rhodium-catalyzed C–H insertion on aliphatic 
alkylsulfonyl diazoacetate substrates initially reported to favor six-membered ring 
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compounds can be reversed by strategically installing alkyl substitutions next to the 
sulfone center. Also, carefully selecting the rhodium catalyst used allows more control 
over the selectivity of the transformation. It has also been demonstrated that it is possible 
to obtain four-membered ring sulfones from select diazo sulfones by intramolecular 
rhodium-catalyzed C–H insertion. The obtained cyclic sulfones are potentially useful 
intermediates in synthesis. These results will be crucial in expanding the scope of this 
research as well as exploring the full synthetic potential of the resulting cyclic sulfones.  
 
2.5 Experimental Section for Rhodium-Catalyzed Intramolecular C–H Insertion Studies 
on Diazosulfones 
 All reactions were carried out under an inert nitrogen atmosphere unless 
otherwise stated. All reagents were used as purchased without further purification except 
otherwise stated. 
1
H-NMR (500 Hz) and 
13
C{
1
H} NMR (125 Hz) spectra were recorded 
on an Avance 500 Bruker spectrometer and calibrated using residual undeuterated solvent 
as internal references. Coupling constants are given in Hz. IR spectra were recorded on a 
Perkin-Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured 
on an AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. 
HRMS data were obtained on an Agilent 61969A TOF high resolution mass spectrometer 
using electrospray ionization (ESI). Melting points were determined on a MEL-TEMP 
melting point apparatus. Analytical TLC was performed using silica gel pre-coated TLC 
plates (E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm 
silica gel (Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) 
was dried by distilling it from sodium and benzophenone in a continuous still under a 
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nitrogen atmosphere. Chloroform, dichloromethane and triethylamine were distilled from 
calcium hydride under an atmosphere of nitrogen. 
 
Procedures for compounds and physical data from Scheme 25 
Compounds 136, 151, 152, 153, 154, 155, 156, and 157 were prepared using the literature 
procedure reported by John et al,
122
 except otherwise stated.  Physical data for 
compounds 136 and 151 have already been reported; however, 
1
H NMR and 
13
C{
1
H} 
NMR are provided. 
 
Ethyl (butylsulfonyl)acetate (151): colorless oil, 
1
H NMR (500 MHz, CDCl3): δ 4.26 (q, 
J = 7, 2H), 3.94 (s, 2H), 3.22–3.26 (m, 2H), 1.81–1.88 (m, 2H), 1.49 (q, J = 7.5, 2H), 
1.31 (t, J = 7, 3H), 0.97 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.3, 62.8, 
57.5, 53.5, 24.0, 21.8, 14.1, 13.6. 
 
Ethyl (hexan-2-ylsulfonyl)acetate (153): pale yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 
4.27 (q, J = 7, 2H), 3.99 (d, J = 14.5, 1H), 3.94 (d, J = 14.5, 1H), 3.35–3.43 (m, 1H), 
1.99–2.07 (m, 1H), 1.52–1.66 (m, 2H), 1.47 (d, J = 6.5, 3H), 1.30–1.45 (m, 6H), 1.42 (t, J 
= 6.5), 1.33 (t, J = 7), 0.94 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.3, 
62.8, 58.2, 55.2, 28.8, 28.3, 22.6, 14.2, 14.0, 12.9. HRMS (ESI) calcd for C10H24NO4S 
[M+NH4]
+  
254.1420, found 254.1404. 
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Ethyl (2-methylhexan-2-ylsulfonyl)acetate (154): pale yellow oil, 
1
H NMR (500 MHz, 
CDCl3): δ 4.28 (q, J = 7, 2H), 3.94 (s, 2H), 1.76–1.81 (m, 2H), 1.30–1.46 (m, 13H), 1.40 
(s), 1.33 (t, J = 7), 0.93 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 162.9, 65.3, 
62.8, 53.3, 35.0, 26.1, 23.3, 20.7, 14.2, 14.1. HRMS (ESI) calcd for C11H26NO4S 
[M+NH4]
+
 254.1577, found 254.1609. 
 
Ethyl (propylsulfonyl)acetate (158.1): colorless oil, 
1
H NMR (500 MHz, CDCl3): δ 4.26 
(q, J = 7.2, 2H), 3.92 (s, 2H), 3.20–3.25 (m, 2H), 1.9 (q, J = 7.5, 2H), 1.32 (t, J = 7.2, 
3H), 1.09 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.2 (C) , 62.9 (CH2), 
57.8 (CH2), 55.4 (CH2), 16.3 (CH2), 14.4 (CH3), 13.5 (CH3). HRMS (ESI) calcd for 
C7H15O4S [M+H]
+
 195.0671, found 195.0691. 
 
Ethyl (2-methylpropylsulfonyl)acetate (159.1): colorless oil, 
1
H NMR (500 MHz, 
CDCl3): δ 4.28 (q, J = 7.2, 2H), 3.94 (s, 2H), 3.17–3.20 (m, 2H), 2.41 (m, 1H), 1.33 (t, J 
= 7.2, 3H), 1.15 (d, J = 6.6, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.6, 63.1, 57.9, 
52.3, 30.9, 27.9, 22.5, 14.5. HRMS (ESI) calcd for C8H17O4S [M+H]
+
 209.0832, found 
209.0847. 
 
Ethyl (3-methylbutylsulfonyl)acetate (160.1): colorless oil, 
1
H NMR (500 MHz, 
CDCl3): δ 4.28 (q, J = 7, 2H), 3.94 (s, 2H), 3.20–3.30 (m, 2H), 1.70-1.80 (m, 4H), 1.32 (t, 
J = 7, 3H), 0.96 (d, J = 6.6, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.6 (C), 63.0 
(CH2), 61.4 (CH2), 59.0 (CH2), 24.3(CH), 23.1 (CH3), 14.1 (CH3). 
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Note: The signal for the diazo carbon was not observed in 
13
C{
1
H} NMR for any of the 
diazo compounds, possibly due to quadrupole broadening. IR spectra showing the diazo 
stretch (2130 cm
-1
) are provided for diazo compounds. 
 
Ethyl (butylsulfonyl)diazoacetate (155): yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 
4.33 (q, J = 7, 2H), 3.35–3.43 (m, 2H), 1.77–1.86 (m, 2H), 1.48 (q, J = 7.5, 2H), 1.33 (t, J 
= 7, 3H), 0.96 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.3, 62.7, 56.6, 
24.8, 21.5, 14.5, 13.7. IR (neat, cm
-1
): 2129, 1714, 1467. 
 
Ethyl (2-hexylsulfonyl)diazoacetate (156): yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 
4.33 (q, J = 7, 2H), 3.44–3.51 (m, 1H), 1.98–2.06 (m, 1H), 1.56–1.65 (m, 1H), 1.44–1.52 
(m, 1H), 1.42 (d, J = 7, 3H), 1.31–1.40 (m, 6H), 1.34 (t, J = 7), 0.94 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz)): δ 160.4, 62.7, 61.7, 28.8, 28.7, 22.6, 14.5, 14.0, 13.2. 
IR (neat, cm
-
1): 2127, 1714, 1463. 
 
Ethyl (propylsulfonyl)diazoacetate (158.2): yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 
4.26 (q, J = 7, 2H), 3.24–3.30(m, 2H), 1.70–1.83 (m, 2H), 1.217 (t, J = 7.2, 3H), 1.02 (t, J 
= 7.2, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.4 (C), 62.9(CH2), 58.6 (CH2), 24.8 
(CH2), 17.1(CH2), 14.9 (CH3), 13.3 (CH3). IR (neat, cm
-1
): 2120. 
Ethyl (2-methylpropylsulfonyl)diazoacetate (159.2): yellow oil, 
1
H NMR (500 MHz, 
CDCl3): δ 4.34 (q, J = 7.2, 2H), 3.28–3.34 (m, 2H), 2.28–2.39 (m, 1H), 1.39 (t, J = 7.2, 
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3H), 1.1 (d, J = 7.2, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.1 (C), 64.6 (CH2), 
62.8(CH2), 24.7 (CH), 22.9 (CH3), 14.7 (CH3). IR (neat, cm
-1
): 2123. 
 
Ethyl (3-methylbutylsulfonyl)diazoacetate (160.2): yellow oil, 
1
H NMR (500 MHz, 
CDCl3): δ 4.33 (q, J = 7.2, 2H), 3.37–3.41 (m, 2H), 1.68–1.72 (m,1H), 1.34 (t, J = 7.2), 
0.96 (d, J = 7.2, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.5 (C), 62.8 (CH2), 55.4 
(CH2), 31.4 (CH), 27.7 (CH3), 22.57(CH3), 14.6 (CH3). IR (neat, cm
-1
): 2125. 
 
General procedure for C–H insertion  
To the suspension of the catalyst (1 mol%) in CH2Cl2 (or ClCH2CH2Cl, 4 
mL/mmol), a solution of the corresponding diazo compound (1 equiv., 0.1–1 mmol) in 
CH2Cl2 (or ClCH2CH2Cl, 2 mL/mmol) was added at rt (or reflux) over a period of 1 h 
using a syringe pump. Upon completion of the addition, the reaction mixture was stirred 
at rt for additional 8 h. The volatiles were removed under reduced pressure. The crude 
reaction mixture was separated on silica column (ethyl acetate–hexanes, 0–40%). 
Typically, it was possible to divide the mixture into three parts—the unpolar 
decomposition products, mixture or various cyclization products, and the more polar six-
membered trans isomer. In some cases, isolation of the cis six-membered product was 
also possible. The incompletely separated mixture of the cyclization products was 
dissolved in CH2Cl2 and treated with 1 equiv. of DBU for 24 h. 1 M HCl solution was 
added, and the reaction mixture was stirred for 15 min. The layers were separated, 
aqueous layer was washed with CH2Cl2, and the combined organic layers were dried and 
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concentrated. The chromatography on silica column (ethyl acetate–hexanes, 0–40%) 
provided the trans five-membered ring product, cis six-membered ring product, and 
additional amount of the trans six-membered product, formed by equilibration from the 
cis isomer. 
 
cis-Ethyl tetrahydro-3-methyl-2H-thiopyran-1,1-dioxide-2-carboxylate (149b): white 
flaky solid, mp 36–37 oC, 1H NMR (500 MHz, CDCl3): δ 4.27 (qd, J = 7, 1, 2H), 3.77 
(dd, J = 4.5, 3, 1H), 3.56 (td, J = 13, 5, 1H), 2.93 (dq, J = 14, 3, 1H), 2.50–2.59 (m, 1H), 
2.04–2.16 (m, 2H), 1.84 (qd, J = 13, 5, 1H), 1.55–1.65 (m, 1H; overlapped with water 
peak), 1.33 (t, J = 7, 3H), 1.06 (d, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 166.3 
(C), 70.1 (CH), 62.4 (CH2), 48.0 (CH2), 34.4 (CH), 26.7 (CH2), 23.3 (CH2), 19.8 (CH3), 
14.3 (CH3). HRMS (ESI) calcd for C9H20NO4S [M+NH4]
+
  238.1107, found 238.1095. 
 
trans-Ethyl tetrahydro-3-ethylthiophene-1,1-dioxide-2-carboxylate (150a): pale 
yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 4.25–4.48 (m, 2H), 3.58 (d, J = 10, 1H), 3.28 
(ddd, J = 13, 7, 2, 1H), 3.10 (td, J = 13, 7, 1H), 2.68–2.77 (m, 1H), 2.35–2.42 (m, 1H), 
1.76–1.86 (m, 1H), 1.60–1.69 (m, 1H), 1.49–1.56 (m, 1H), 1.34 (t, J = 7, 3H), 0.97 (t, J = 
7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 165.8 (C), 70.9 (CH), 62.9 (CH2), 52.9 
(CH2), 41.7 (CH), 27.4 (CH2), 26.3 (CH2), 14.3 (CH3), 11.5 (CH3). HRMS (ESI) calcd 
for C9H17O4S [M+H] 221.0842, found 221.0854, C9H20NO4S [M+NH4] 238.1107, found 
238.1121. 
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Ethyl tetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (155.1): pale yellow oil, 
1
H 
NMR (500 MHz, CDCl3): δ 4.24–4.34 (m, 2H), 3.85 (ddd, J = 6.5, 4.5, 2, 1H), 3.45 (ddd, 
J = 14, 9, 4.5, 1H), 2.95–3.02 (m, 1H), 2.26–2.39 (m, 2H), 2.07–2.17 (m, 2H), 1.89–1.98 
(m, 1H), 1.57–1.65 (m, 1H), 1.33 (t, J = 7, 3H). 13C{1H} NMR (CDCl3, 125 MHz): δ 
166.1 (C), 65.2 (CH), 62.6 (CH2), 51.1 (CH2), 28.1 (CH2), 24.3 (CH2), 20.1 (CH2), 14.2 
(CH3). HRMS (ESI) calcd for C8H18NO4S [M+NH4]
+
 224.0951, found 224.0951. 
 
trans-Ethyl tetrahydro-3-methylthiophene-1,1-dioxide-2-carboxylate (155.2): white 
flaky solid, mp 42–44 oC, 1H NMR (500 MHz, CDCl3): δ 4.25–4.39 (m, 2H), 3.52 (d, J = 
10.5, 1H), 3.31 (ddd, J = 13, 7, 1.5, 1H), 3.13 (td, J = 13, 7, 1H), 2.76–2.87 (m, 1H), 
2.30–2.36 (m, 1H), 1.82 (qd, J = 13, 7, 1H), 1.34 (t, J = 7, 3H), 1.22 (d, J = 6.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 165.1 (C), 72.3 (CH), 62.9 (CH2), 53.4 (CH2), 35.2 
(CH), 28.7 (CH2), 19.2 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C8H15NO4S [M+H] 
207.0686, found 207.0695; C8H14NO4NaS [M+Na]
+
 229.0505, found 207.0515. 
 
(2R,3R,6R)-Ethyl tetrahydro-3,6-dimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate 
(156.1): white solid, mp 102–103 oC, 1H NMR (500 MHz, CDCl3): δ 4.33 (qd, J = 7, 4, 
2H), 3.51 (d, J = 12, 1H), 2.87–2.96 (m, 1H), 2.52–2.60 (m, 1H), 1.88–1.99 (m, 3H), 1.38 
(d, J = 6.5, 3H), 1.27–1.36 (m, 4H), 1.34 (t, J = 7), 1.03 (d, J = 6.5, 3H). 13C{1H} NMR 
(CDCl3, 125 MHz): δ 163.8 (C), 73.0 (CH), 62.6 (CH2), 57.6 (CH), 34.8 (CH), 33.1 
(CH2), 31.4 (CH2), 19.9 (CH3), 14.4 (CH3), 10.9 (CH3). HRMS (ESI) calcd for 
C10H22NO4S [M+NH4]
+
 252.1264, found 252.1255. 
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(2S,3R,6R)-Ethyl tetrahydro-3,6-dimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate 
(156.2): white solid, mp 77–78 oC, 1H NMR (500 MHz, CDCl3): δ 4.27 (q, J = 7, 2H), 
3.83 (d, J = 4.5, 1H), 3.60–3.68 (m, 1H), 2.51–2.59 (m, 1H), 1.81–2.02 (m, 3H), 1.55–
1.61 (m, 1H; overlapped with water peak), 1.35 (δ, J = 7, 3H), 1.33 (t, J = 7, 3H), 1.06 (d, 
J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): d 166.4 (C), 70.0 (CH), 62.3 (CH2), 52.7 
(CH), 34.7 (CH), 31.6 (CH2), 27.7 (CH2), 19.7 (CH3), 14.3 (CH3), 10.7 (CH3). HRMS 
(ESI) calcd for C10H19NO4S [M+H]
+
 235.0999, found 235.1014. 
 
(2S,3S,5R)-Ethyl tetrahydro-3-ethyl-5-methylthiophene-1,1-dioxide-2-carboxylate 
(153.2): pale yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 4.25–4.37 (m, 2H), 3.57 (d, J = 
10, 1H), 3.14–3.24 (m, 1H), 2.60–2.70 (m, 1H), 2.37 (dt, J = 13, 6.5, 1H), 1.55–1.64 (m, 
1H; overlapped with the water peak at δ 1.60), 1.42–1.52 (m, 2H), 1.39 (d, J = 6.5, 3H), 
1.34 (t, J = 7, 3H), 0.94 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 166.1 (C), 
70.7 (CH), 62.9 (CH2), 58.6 (CH), 39.2 (CH), 34.5 (CH2), 27.6 (CH2), 14.3 (CH3), 11.4 
(CH3), 11.1 (CH3). HRMS (ESI) calcd for C10H22NO4S [M+NH4]
+
 252.1264, found 
252.1250. 
 
trans-Ethyl tetrahydro-3,6,6-trimethyl-2H-thiopyran-1,1-dioxide-2-carboxylate 
(157.1): pale yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 4.30–4.37 (m, 2H), 3.73 (d, J = 
12, 1H), 2.52–2.61 (m, 1H), 2.16–2.23 (m, 1H), 1.71–1.77 (m, 2H), 1.44–1.51 (m, 4H), 
1.47 (s), 1.40 (s, 3H), 1.34 (t, J = 7, 3H), 1.03 (d, J = 6.5, 3H). 
13
C{
1
H} NMR (CDCl3, 
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125 MHz): δ 164.1 (C), 67.8 (CH), 62.6 (CH2), 59.0 (C), 36.5 (CH2), 34.8 (CH), 28.7 
(CH2), 21.5 (CH3), 21.1 (CH3), 20.0 (CH3), 14.4 (CH3). HRMS (ESI) calcd for 
C11H24NO4S [M+NH4]
+
 266.1421, found 266.1411. 
 
trans-Ethyl tetrahydro-3-ethyl-5,5-dimethylthiophene-1,1-dioxide-2-carboxylate 
(157.2): pale yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 4.26–4.37 (m, 2H), 3.61 (d, J = 
9.5, 1H), 2.73–2.82 (m, 1H), 2.10 (dd, J = 13, 6.5, 1H), 1.73 (t, J = 13, 1H), 1.48–1.55 
(m, 2H; overlapped with the water peak at δ 1.60), 1.42 (s, 3H), 1.44 (s, 3H), 1.34 (t, J = 
7, 3H), 0.92 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 166.4 (C), 71.3 (CH3), 
62.8 (CH2), 62.3 (C), 41.5 (CH2), 37.2 (CH), 28.1 (CH2), 22.1 (CH3), 21.5 (CH3), 14.3 
(CH3), 11.6 (CH3). HRMS (ESI) calcd for C11H21NO4S [M+H] 249.1155, found 
249.1176; C11H24NO4S [M+NH4]
+
 266.1421, found 266.1441. 
 
Ethyl 3,3-dimethylthiotane-1,1-dioxide-2-carboxylate (159.2.2): pale yellow oil, 
1
H 
NMR (500 MHz, CDCl3): δ 2.64 (s, 1H), 4.20-4.25 (m, 2H), 3.7-3.8 (dd, J = 12.9, 12.6, 
2H), 1.47-1.49 (s, 6H; overlapped with the water peak at δ 1.60), 1.20 (t, J = 7.2, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.3 (C), 84.5 (CH), 74.9 (CH2), 62.4 (CH2), 29.4 
(C), 28.5 (CH3), 24.0 (CH3), 14.5 (CH3). 
Ethyl (2-methyl-2-propenylsulfonyl)acetate (161): pale yellow oil, 
1
H NMR (500 
MHz, CDCl3): δ 5.29-5.27 (δ, J = 11.3), 4.30 (q, J = 7.2, 2H), 3.9-4.10 (d, J = 23.3, 2H), 
2.0 (s, 3H), 1.34 (t, J = 7.2, 3H), 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.5 (C), 134.1 
(CH), 121.5 (C), 63.0 (CH2), 61.4 (CH2), 55.0 (CH2), 22.9 (CH3), 14.3 (CH3).  
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Ethyl tetrahydro-2-ethyl-3,3-dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2): 
pale yellow oil, 
1
H NMR (500 MHz, CDCl3): δ 4.22-4.38 (m, 2H), 3.65 (s, 1H), 3.24-
3.40 (m, 2H), 2.26-2.40 (m, 1H), 1.85-2.10 (m, 1H), 1.36 (s, 3H), 1.34 (t, J = 7.2, 3H), 
1.33 (s, 3H).  
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 165.1 (C), 75.0 (CH2), 62.5 (CH), 
52.6 (CH2), 40.9 (CH2), 36.2 (CH), 29.3 (CH3), 24.5 (CH3), 14.7 (CH3). HRMS (ESI) 
calcd for C9H17O4S [M+H] 221.0862, found 221.0847. 
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CHAPTER 3 
 ENANTIOSELECTIVE RHODIUM-CATALYZED INTRAMOLECULAR C–H 
INSERTION ON DIAZOSULFONES 
3.1 Introduction 
The factors, which determine the regioselectivity of rhodium-catalyzed 
intramolecular C–H insertion reactions on diazosulfones, have been disclosed by Jungong 
and co-workers
124
 and are discussed in the previous chapter. However, the 
enantioselective version of these transformations remains largely unexplored. To date, 
there is only a single report on enantioselective intramolecular C–H insertion on 
diazosulfones published in 2009 by Maguire and co-workers.
126
 In this report, chiral 
copper bis-oxazoline catalysts have been employed for C–H insertion reactions on 
diazosulfones to afford cis-thiopyrans in moderate yields (21-68%) but excellent 
enantioselectivities (85-98%) (Table 9)
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Table 9. Enantioselective intramolecular copper-catalyzed C–H insertion reactions of 
diazosulfones reported by Maguire and co-workers.
126
 
 
 
S R R1 Yield (%) ee (%) 
163 OMe Ph 47 98 
164 OMe 4-tolyl 64 96 
165 OMe 4-anisole 56 91 
166 OMe 4-nitrophenyl - - 
167 OMe benzyl 42 96 
168 OMe ethyl 68 97 
169 OBn octyl 66 90 
170 OBn octyl 21 70 
171 Me Ph 30 85 
172 Ph Ph 49 97 
 
 
Enantioselective rhodium-catalyzed intramolecular C–H insertion reactions have 
been performed on diazocarbonyl substrates using chiral rhodium catalysts.
51, 98, 127, 128
 
Most of these catalysts are derived by simple ligand displacement reactions from 
rhodium(II) tetraacetate. Prior to the advent of chiral rhodium catalysts, control of 
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diasrereoselectivity in intramolecular C–H insertion reactions had been attained by using 
chiral diazocarbonyl compounds, which favored 1,2- and 1,3-asymmetric inductions.
129, 
130
 For fused ring systems, asymmetric induction has been observed by exploiting the 
preferential insertion into equatorial over axial C–H bonds.131 The groups of Taber128 and 
Wee
132
 have also demonstrated the use of chiral auxiliaries to control diastereoselectivity 
in rhodium-catalyzed intramolecular C–H insertion reactions. 
Enantioselective rhodium-catalyzed intramolecular C–H insertion on 
diazosulfones has not yet been reported. This prompted further investigation into the 
feasibility of controlling diastereoselectivity during the rhodium-catalyzed intramolecular 
C–H insertion event on diazosulfones. For this study, diazosulfone 136 was used as the 
model substrate for C–H insertion. Several chiral rhodium catalysts were screened, 
aiming to optimize the yield and enantioselectivity of the transformation. 
 
3.2 Results and Discussion 
Jungong and co-workers
124
 have demonstrated that intramolecular C–H insertion 
on diazosulfone 136 using achiral dirhodium catalyst Rh2(OAc)4 14 would result to the 
formation of eight possible diastereomers: four six-membered ring sulfones and four five-
membered ring sulfones (Scheme 27). The four diasteromers for each class of sulfones 
(six- or five-membered) comprise of two trans enantiomers (R,R and S,S) and two cis 
enantiomers (R,S and S,R), and the trans enantiomers were isolated as major products 
over the cis enantiomers.  
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Scheme 27. Formation of six- and five-membered sulfones by intramolecular C–H 
insertion reported by Jungong and co-wokers.
124
 
 
 
The formation of eight possible diastereomers greatly limits the synthetic utility 
of this transformation, mandating the need to establish reaction conditions that would 
favor the formation of a single diastereomer. To this end, the primary objective was to 
originate reaction conditions, which would allow the formation of just one six-membered 
enantiomer. The work reported by Jungong and co-workers identified diazosulfone 136 to 
preferentially favor the formation of six- over five-membered sulfones, which favored the 
decision to use it as the model substrate for these studies. 
Efforts to effectively isolate and characterize the cis isomers turned out to be 
unexpectedly difficult, so the enantioselectivity was determined as an enantiomeric ratio 
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(er) between the trans enantiomers (R,R and S,S). The er  for each reaction was deduced 
by subjecting the obtained six-membered sulfone trans isomers to a DIBALH reduction, 
followed by Steglich esterification of the resulting alcohol with (S)-acetylmandelic acid 
in the presence of DCC (N,N'-dicyclohexylcarbodiimide) and DMAP (4-
dimethylaminopyridine) (Scheme 28).  
 
 
Scheme 28. Synthesis of sulfonyl acetylmandalates for determination of enantiomeric 
ratio. 
 
The crude reaction mixture was analyzed by 
1
H NMR without prior purification to 
guarantee that the enantiomeric ratio remained undistorted. Two sets of peaks were used 
to assign enantiomeric ratios; the doublet peaks between 0.5-1 ppm corresponding to the 
methyl group next to the C–H insertion center, and the singlets between 5.8-6.5 ppm 
corresponding to the proton adjacent to the acetate moiety (Figure 7). The observed 
enantiomeric ratios were consistent for both peaks.  
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Figure 7. 
1
H NMR spectrum of sulfonyl acetylmandalate showing peaks used for 
enantiomeric ratio determination. 
 
 
The study was initiated by screening various chiral rhodium catalysts for this 
transformation (Figure 9). Rh2(S-MEPY)4 17 and Rh2(S-DOSP)4 15, which have been 
very effective in other cases, showed poor results, providing moderate yields (45-55%), 
and poor enantioselectivity (1:1 to 1.2 :1 er) (Table 10).
65, 133
 Use of non-polar solvent 
(2,2-dimethylbutane) with 15 provided the first glimpse of selectivity (1.2 :1 er) (Table 
10), although complications arose due to poor solubility of the diazo compound in this 
solvent. Rh2(S-MEPY)4 was unreactive in DCM at room temperature, requiring reflux in 
the higher boiling solvent dichloroethane. Next, the class of catalysts derived from 
phthalimide-protected amino acids was explored, starting with Rh2(S-pttl)4, derived from 
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tert-leucine. This provided the first encouraging result (2.5: 1 er). The additional bonus 
was the increased yield of the product (85%).  
 
 
Figure 8. Chiral rhodium(II) carboxylate catalysts screened for enantioselective 
intamolecular C–H insertion. 
 
Following this lead, it was logical to modify the backbone of Rh2(S-pttl)4 catalyst 
to ascertain what effect that would have on the outcome of the transfromation. Increasing 
and decreasing the size of the substituents at the amino acid center would alter its 
catalytic pocket, which in turn will have an effect on the yield and the selectivity. 
Substituting tert-butyl group with a benzyl moiety (Rh2(S-ptpa)4) 177 decreased the yield 
and selectivity to 70% and 2:1, respectively. However, introduction of the bulky 
adamantyl group (Rh2(S-ptad)4) 176 at the same position improved the yield to 90% but 
at the detriment of the enantioselectivity  which dropped to 2:1 er. Surprisingly, 
increasing the size of the phthaloyl group by introducing a tert-butyl group at the 4-
position (Rh2(S-tpttl)4) 178, slightly raised the yield to 88% but reversed the 
enantioselectivity to 1:2 er. When the phthaloyl substituent was replaced by the bulkier 
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N-naphthaloyl group (Rh2(S-nttl)4) 179, the yield was maintained at 88%, while the 
enantioselectivity remained unreversed, but dropped slightly to 2.3:1 er. Maintaining the 
N-naphthtaloyl group and replacing the tert-butyl group with a benzyl group Rh2(S-ntpa)4 
181, held the yield at 87% but further dropped the enantioselectivity to 2:1 er. On the 
other hand, the use of Rh2(S-nta)4 180, where the N-naphthtaloyl group is maintained, but 
the size of the tert-butyl group is decreased to a methyl group, dropped the 
enantioselectivity even further to 1.8:1 er, even though the yield remained at 87%. 
Because all modifications failed to increase the enantioselectivity compared to Rh2(S-
pttl)4, it was used as the model catalyst for investigating optimal reaction conditions. 
 
 
Table 10. Effect of chiral rhodium(II) carboxylate catalyst on the enantioselectivity of 
intramolecular C–H insertion on diazosulfones. 
 
Entry Rh2L4, conditions Yield (%) er 
1 Rh2(S-MEPY)4, 80 
o
C, (CH2Cl)2 55 1:1 
2 Rh2(S-DOSP)4, rt, DCM 50 1.05:1 
3 Rh2(S-DOSP)4, rt, 2,2-dimethylbutane 45 1.2:1 
4 Rh2(S-pttl)4, rt, DCM 85 2.5:1 
5 Rh2(S-ptad)4, rt, DCM 90 2:1 
6 Rh2(S-ptpa)4, rt, DCM 70 2:1 
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Table 10. Cont. 
 Rh2L4, conditions Yield (%) er 
7 Rh2(S-nttl)4, rt, DCM 88 2.3:1 
8 Rh2(S-ntpa)4, rt, DCM 86 2:1 
9 Rh2(S-nta)4, rt, DCM 87 1.8:1 
 
 
Enantioselective rhodium-catalyzed intramolecular C–H insertion reactions on 
diazocarbonyl compounds have been shown to afford better selectivities when carried out 
at lower temperatures.
51, 134
 In this light, the reaction temperature was decreased to 0 
o
C, 
then to -20 
o
C, maintaining DCM as the solvent. In both cases, the enantioselectivity was 
increased to 3:1 er but at the detriment to the yield which dropped to 65% and 61%, 
respectively. The reason appears to be the lack of decomposition of the diazosulfone at 
temperatures significantly below 0 
o
C. Switching the solvent to toluene at room 
temperature also raised the enantioselectivity to 3:1 er but reduced the yield to 78%. 
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Table 11. Effect of temperature and solvent on the enantioselectivity of rhodium-
catalyzed intramolecular C–H insertion of diazosulfones. 
 
Entry Conditions Yield (%) er 
1 
2 
3 
Rh2(S-pttl)4, 0 
o
C, DCM 65 3:1 
Rh2(S-pttl)4, -20 
o
C, DCM 61 3:1 
Rh2(S-pttl)4, rt, toluene 78 3:1 
 
 
The next phase of the study was to investigate the effect of the structure of 
diazosulfone 136 on the enantioselectivity and yield (Table 12). This entailed maintaining 
the catalyst as Rh2(S-pttl)4, while modifying the ester substituent. The necessary diazo 
substrates were prepared as previously described. Several transesterification conditions 
were tested to transform sulfone 151 to the desired sulfone esters, but were not effective. 
However, base-catalyzed hydrolysis of 151 using potassium hydroxide in methanol 
furnished sulfone acid 182. The resulting acid 182 was then coupled to various alcohols 
by employing Yamaguchi esterification conditions in the presence of DMAP, benzoyl 
chloride and TEA (triethylamine). The obtained sulfone esters were subjected to diazo 
transfer conditions (NosN3, DIPEA, DMF) to provide the desired diazosulfones, which 
were treated with Rh2(S-pttl)4 in DCM at rt. 
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Table 12. Preparation of diazosulfonyl acetates. 
 
R Sulfone diazosulfone Yield of sulfone 
(%) 
Yield of diazosulfone 
(%) 
Me 183 189 90 91 
i-Pr 184 190 85 88 
t-Bu 185 191 87 90 
(+)-menthyl 186 192 90 92 
(-)-menthyl 187 193 87 80 
CH(i-Pr)2 188 194 86 94 
 
 
Decreasing (methyl) or increasing (isopropyl, tert-butyl, and diisopropyl) the size 
of the ester substituent had no significant effect on the yield and selectivity. Notably, the 
selectivity dropped to 2:1 er when the ester substituent become even bulkier 
(diisopropyl).  
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Table 13. Effect of diazosulfone substrates on the enantioselectivity of rhodium-catalyzed 
intramolecular C–H insertion. 
 
Entry R Product Rh2L4 Yield (%) er 
1 Me 195 Rh2(S-pttl)4, rt, DCM 85 2.5:1 
2 i-Pr 196 Rh2(S-pttl)4, rt, DCM 81 2.2:1 
3 t-Bu 197 Rh2(S-pttl)4, rt, DCM 32 (82)* 2.5:1 
4 (+)-menthyl 198 Rh2(S-pttl)4, rt, DCM 82 1:2 
5 (-)-menthyl 199 Rh2(S-pttl)4, rt, DCM 94 20:1 
6 (-)-menthyl 199 Rh2(OAc)4, rt, DCM 70 1:1 
7 CH(i-Pr)2 200 Rh2(S-pttl)4, rt, DCM 83 2:1 
 
*Partial de-tert-butylation appeared to happen during the reaction.  
 
 
The introduction of a chiral ester substituent, (-)-menthyl, amplified both the yield 
and enantioselectivity to 94% and 20:1 er, respectively. Unexpectedly, the use of 
Rh2(OAc)4 with the chiral menthyl diazosulfone decreased the yield to 60%, with no 
selectivity (1:1 er). The use of (+)-menthyl reversed the enantioselectivity towards the 
other enantiomer, but decreased the ratio to 1:2 er. This confirms that the (-)-menthyl 
group acts as a directing chiral auxiliary and not a bulky group, and the observed 
selectivity of 20:1 is a synergic cooperative effect.  
 74 
 
To ascertain the absolute configuration of the obtained C–H insertion products, 
sulfone 149 was synthesized in enantiopure fashion by an independent method (Scheme 
29). Enatiopure (R)-pentane-1,4-diol 201 was obtained as described from L-glutamic 
acid
135
 and converted to ditosylate. Selective substitution of the primary tosylate with 
ethyl thioglycolate followed by oxidation yielded sulfone. Its treatment with a base in 
DMSO gave 149 via intramolecular SN2 substitution, along with a cis isomer. The 
configuration of the product was assigned to be 2S,3S, assuming inversion in the course 
of substitution. The optical rotation of the alcohol, obtained upon reduction of this 
product, along with NMR analysis of its acetylmandalate indicated that it is the 
enantiomer of the material obtained by reduction of 199. 
 
 
Scheme 29. Synthesis of enantiopure sulfone 149. 
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3.3 Experimental Section for Enantioselective Rhodium-Catalyzed Intramolecular C–H 
Insertion on Diazosulfones 
All reactions were carried out under an inert nitrogen atmosphere unless otherwise stated.  
All reagents were used as purchased without further purification unless otherwise stated. 
1
H-NMR (500 Hz) and 
13
C{
1
H} NMR (125 Hz) spectra were recorded on an Avance 500 
Bruker spectrometer and calibrated using residual undeuterated solvent as internal 
references. Coupling constants are given in Hz. IR spectra were recorded on a Perkin-
Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured on an 
AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. HRMS 
data were obtained on an Agilent 61969A TOF high resolution mass spectrometer using 
electrospray ionization (ESI). Melting points were determined on a MEL-TEMP melting 
point apparatus. Analytical TLC was performed using silica gel pre-coated TLC plates 
(E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm silica gel 
(Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) was dried 
by distilling it from sodium and benzophenone in a continuous still under a nitrogen 
atmosphere. Chloroform, dichloromethane and triethylamine were distilled from calcium 
hydride under an atmosphere of nitrogen. 
 
Preparation of (pentylsulfonyl)acetic acid (182) 
To a solution of ethyl (pentylsulfonyl)acetate (720 mg, 3.24 mmol), dissolved in 
MeOH (8 mL), was added KOH (85%, 250 mg, 3.80 mmol), dissolved in MeOH (8 mL), 
at rt. The resulting solution was then stirred for 3 h, after which the reaction was 
complete as indicated by TLC analysis. The reaction mixture was concentrated under 
 76 
 
reduced pressure, diluted with water (20 mL), washed with dichloromethane (3 × 10 mL), 
diluted with 20 mL of 1N HCl solution, and extracted with ethyl acetate (3 × 20 mL). The 
ethyl acetate extract was washed with brine, dried over anhydrous Na2SO4 and 
evaporated under reduced pressure to afford 178 (570 mg, 91%) as a white crystalline 
powder that was used without further purification. 
 
 (Pentylsulfonyl)acetic acid (182): m.p. 78-79 
o
C. 
1
H NMR (CDCl3, 500 MHz): δ 9.20 
(br s, 1H), 4.04 (s, 2H), 3.26-3.31 (m, 2H), 1.85-1.93 (m, 2H), 1.35-1.50 (m, 4H), 0.94 (t, 
J = 7.3, 3H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 170.0 (C), 57.3 (CH2), 54.0 (CH2), 
30.6 (CH2), 22.3 (CH2), 21.7 (CH2), 13.9 (CH3). HRMS (ESI) calcd for C17H18O4NS 
[M+NH4]
+
  212.0956, found 
212.0983. 
 
General procedure for preparation of sulfonylacetates (183-188) 
 (Pentylsulfonyl)acetic acid (182, 1 equiv.), benzoyl chloride (1 equiv.) and THF 
(2.5 mL/mmol) were charged to a round bottom flask, equipped with a magnetic stirrer. 
To the resulting solution Et3N (2 equiv.) was added slowly, followed by the 
corresponding alcohol (1 equiv.), and DMAP (0.25 equiv.). The obtained mixture was 
stirred at rt for 6 h (TLC analysis revealed the reaction was complete). The reaction 
mixture was diluted with EtOAc (40 mL) and washed with water (3 × 30 mL). The 
organic phase was further washed with brine, dried over anhydrous Na2SO4 and 
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evaporated under reduced pressure to afford the crude product that was purified by flash 
chromatography on a silica gel column using EtOAc-hexanes (0:1 to 1:9). 
 
Methyl (pentylsulfonyl)acetate (183): 
1
H NMR (CDCl3, 500 MHz): δ 3.96 (s, 2H), 3.83 
(s, 3H), 3.22-3.27 (m, 2H), 1.83-1.91 (m, 2H), 1.34-1.48 (m, 4H), 0.93 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.8 (C), 57.4 (CH2), 53.7 (CH2), 53.5 (CH3), 30.6 
(CH2), 22.3 (CH2), 21.7 (CH2), 13.9 (CH3). HRMS (ESI) calcd for C8H17O4S [M+H]
+
  
209.0842, found 209.0848.  
 
Isopropyl (pentylsulfonyl)acetate (184): 
1
H NMR (CDCl3, 500 MHz): δ 5.11 (septet, J 
= 6.5, 1H), 3.91 (s, 2H), 3.22-3.27 (m, 2H), 1.84-1.92 (m, 2H), 1.34-1.48 (m, 4H), 1.31 
(d, J= 6.5, 6H), 0.93 (t, J = 7, 3H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 162.8 (C), 70.9 
(CH), 57.8 (CH2), 53.7 (CH2), 30.6 (CH2), 22.3 (CH2), 21.7 (CH2), 21.8 (CH3), 13.9 
(CH3). HRMS (ESI) calcd for C10H21O4S [M+H]
+ 
  237.1160, found 237.1158. 
 
 t-Butyl (pentylsulfonyl)acetate (185): 
1
H NMR (CDCl3, 500 MHz): δ 3.86 (s, 2H), 
3.21-3.25 (m, 2H), 1.83-1.90 (m, 2H), 1.51 (s, 9H), 1.33-1.48 (m, 4H), 0.92 (t, J = 7, 3H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 162.3 (C), 84.3 (C), 58.6 (CH2), 53.6 (CH2), 30.6 
(CH2), 28.0 (CH3), 22.3 (CH2), 21.8 (CH2), 13.9 (CH3). HRMS (ESI) calcd for 
C11H26O4NS [M+NH4]
+
 268.1582, found 268.1588. 
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2,4-Dimethyl-3-pentyl (pentylsulfonyl)acetate (186): 
1
H NMR (CDCl3, 500 MHz): δ 
4.69 (t, J = 6, 1H), 3.97 (s, 2H), 3.24-3.28 (m, 2H), 1.84-2.00 (m, 4H), 1.33-1.48 (m, 
4H),0.92 (t, J = 7.5, 3H), 0.91 (t, J = 6, 12H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 163.4 
(C), 86.2 (CH), 57.5 (CH2), 53.7 (CH2), 30.6 (CH2), 29.6 (CH), 22.3 (CH2), 21.9 (CH2), 
19.6 (CH3), 17.3 (CH3), 13.9 (CH3). HRMS (ESI) calcd for C14H32NO4S [M+NH4]
+
 
310.2052, found 310.2054. 
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)acetate (187): [α]D
20 
= -
45.9
o
 (c 3.5, CHCl3). 
1
H NMR (CDCl3, 500 MHz): δ 4.79 (td, J = 11, 4.5, 1H), 3.93 (s, 
2H),3.20-3.29 (m, 2H), 2.01-2.07 (m, 1H), 1.84-1.96 (m, 3H), 1.68-1.74 (m, 2H), 1.34-
1.55 (m, 6H), 1.02-1.12 (m, 2H), 0.85-0.96 (m, 10H), 0.77 (d, J = 7, 3H). 
13
C{
1
H}  NMR 
(CDCl3, 125 MHz): δ 163.0 (C), 77.4 (CH), 57.9 (CH2), 53.8 (CH2), 47.0 (CH), 40.7 
(CH2), 34.3 (CH2), 31.7 (CH), 30.7 (CH2), 26.3 (CH), 23.4 (CH2), 22.3 (CH3), 22.1 
(CH2), 21.8 (CH3), 20.9 (CH3), 16.2 (CH3), 13.9 (CH3). HRMS (ESI) calcd for 
C17H36NO4S [M+NH4]
+
  350.2365, found 350.2350.  
 
(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)acetate (188) (enantiomer 
of 187, from (+)-menthol): Spectral data were identical to 187. [α]D
20
 = +45.7
o
 (c 3.1, 
CHCl3). 
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General procedure for preparation of sulfonyldiazoacetates (189-194) 
The corresponding alkyl (pentylsulfonyl)acetate (1 equiv.) was dissolved in THF 
(2.5 mL/mmol) and cooled to -45 
o
C. Mesyl azide (2.5 equiv.) was added, followed by 
dropwise addition of 1.5 equiv. of DBU. The reaction mixture was stirred for 1 h, 
maintaining the temperature at -45 
o
C, after which it was warmed up to rt over a 15-20 
min interval. The obtained mixture was poured over 20 mL of a half-saturated (NH4)2SO4 
solution, extracted with DCM (3 × 20 mL), dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to afford the crude product that was purified by 
flash chromatography on a silica gel column using EtOAc-hexanes (0:1 to 1:9). 
Note: The diazo carbon does not appear in the 
13
C{
1
H}  NMR spectra of all diazo 
compounds. IR spectra show a strong diazo stretch at ~ 2130 cm
-1
. 
 
Methyl (pentylsulfonyl)diazoacetate (189): 
1
H NMR (CDCl3, 500 MHz): δ 3.87 (s, 3H), 
3.35-3.40 (m, 2H), 1.80-1.87 (m, 2H), 1.32-1.46 (m, 4H), 0.92 (t, J = 7, 3H). 
13
C{
1
H}  
NMR (CDCl3, 125 MHz): δ 160.7 (C), 56.8 (CH2), 53.3 (CH3), 30.3 (CH2), 22.5 (CH2), 
22.3 (CH2), 13.9 (CH3). IR (CH2Cl2, cm
-1
): 2132, 1719, 1338, 1147.  
 
Isopropyl (pentylsulfonyl)diazoacetate (190): 
1
H NMR (CDCl3, 500 MHz): δ 5.18 
(septet, J = 6.5, 1H), 3.35-3.41 (m, 2H), 1.80-1.87 (m, 2H), 1.32-1.46 (m, 4H), 1.32 (d, J 
= 6.5, 6H), 0.91 (t, J = 7, 3H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 159.9 (C), 71.0 
(CH), 56.7 (CH2), 30.3 (CH2), 22.5 (CH2), 22.3 (CH2), 22.0 (CH3), 13.9 (CH3). IR 
(CH2Cl2, cm
-1
): 2131, 1710, 1341, 1147. 
 80 
 
t-Butyl (pentylsulfonyl)diazoacetate (191): 
1
H NMR (CDCl3, 500 MHz): δ 3.34-3.39 
(m, 2H), 1.80-1.87 (m, 2H), 1.54 (s, 9H), 1.33-1.47 (m, 4H), 0.93 (t, J = 7, 3H). 
13
C{
1
H}  
NMR (CDCl3, 125 MHz): δ 159.4 (C), 85.1 (C), 56.6 (CH2), 30.3 (CH2), 28.5 (CH3), 22.6 
(CH2), 22.3 (CH2), 13.9 (CH3). IR (CH2Cl2, cm
-1
): 2128, 1708, 1338, 1146.  
 
2,4-Dimethyl-3-pentyl (pentylsulfonyl)diazoacetate (192): 
1
H NMR (CDCl3, 500 
MHz): δ 4.75 (t, J = 6, 1H), 3.35-3.40 (m, 2H), 1.93-2.01 (m, 2H), 1.79-1.87 (m, 2H), 
1.32-1.46 (m, 4H), 0.89-0.94 (m, 15H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 160.6 (C), 
86.2 (CH), 56.7 (CH2), 30.3 (CH2), 29.7 (CH), 22.8 (CH2), 22.3 (CH2), 19.7 (CH3), 17.4 
(CH3), 13.9 (CH3). IR (CH2Cl2, cm
-1
): 2130, 1709, 1338, 1147.  
 
(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)diazoacetate (193): [α]D
20
 
= -56.5
o
 (c 2.1, CHCl3).
1
H NMR (CDCl3, 500 MHz): δ 4.86 (td, J = 11, 4.5, 1H), 3.31-
3.42 (m, 2H), 2.02-2.08 (m, 1H), 1.78-1.89 (m, 3H), 1.66-1.74 (m, 2H), 1.31-1.56 (m, 
6H), 1.02-1.12 (m, 2H), 0.83-0.94 (m, 10H), 0.78 (d, J = 7, 3H). 
13
C{
1
H}  NMR (CDCl3, 
125 MHz): δ 160.0 (C), 77.3 (CH), 56.7 (CH2), 47.2 (CH), 41.1 (CH2), 34.2 (CH2), 31.6 
(CH), 30.3 (CH2), 26.6 (CH), 23.6 (CH2), 22.6 (CH2), 22.3 (CH2), 22.1 (CH3), 20.9 
(CH3), 16.5 (CH3), 13.9 (CH3). IR (CH2Cl2, cm
-1
): 2131, 1705, 1336, 1146. 
 
(1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl (pentylsulfonyl)diazoacetate (194) 
(enantiomer of 193, from (+)-menthol): Spectral data were identical to 193. [α]D
20
 = 
+54.7
o
 (c 3.5, CHCl3). 
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General procedure for C-H insertion (195-200) 
To the solution of Rh(II) catalyst (1 mol%) in CH2Cl2 (2.5 mL/mmol) was added 
the corresponding alkyl(pentylsulfonyl)diazoacetate (1 equiv.) dissolved in DCM (2.5 
mL/mmol) over 2 h via a syringe pump. The resulting mixture was stirred at rt for 12 h 
after which the reaction was complete as indicated by TLC analysis. The reaction mixture 
was then evaporated under reduced pressure to afford the crude product that was purified 
by flash chromatography using EtOAc-hexanes. 
 
trans-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (149): The 
data matched previously reported. 
 
trans-Methyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (195): 
1
H 
NMR (CDCl3,500 MHz): δ 3.86 (s, 3H), 3.58 (d, J = 11, 1H), 3.18 (dt, J = 14, 4, 1H), 
2.88-2.96 (m, 1H), 2.52-2.62 (m, 1H), 2.09-2.23 (m, 2H), 1.94-2.01 (m, 1H), 1.23-1.33 
(m, 1H), 1.07 (d, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 164.5 (C), 72.7 (CH), 
53.4 (CH3), 52.0 (CH2), 34.5 (CH), 32.0 (CH2), 22.9 (CH2), 20.0 (CH3). HRMS (ESI) 
calcd for C8H15O4S [M+H]
+
 207.0691, found 207.0668. 
 
trans-Isopropyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (196): 
1
H NMR (CDCl3, 500 MHz): δ 5.18 (septet, J = 6.5, 1H), 3.52 (d, J = 11, 1H), 3.16 (dt, J 
= 14, 4, 1H), 2.86-2.94 (m, 1H), 2.51-2.61 (m, 1H), 2.08-2.23 (m, 2H), 1.93-1.99 (m, 
1H), 1.33 (d, J = 6.5, 3H), 1.32 (d, J = 6.5, 3H), 1.23-1.30 (m, 1H), 1.08 (d, J = 6.5, 3H). 
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13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.5 (C), 72.9 (CH), 70.6 (CH), 52.0 (CH2), 34.5 
(CH), 32.0 (CH2), 22.8 (CH2), 21.9 (CH3), 21.8 (CH3), 19.8 (CH3). HRMS (ESI) calcd 
for C10H22O4NS [M+NH4]
+
 252.1269, found 252.1390. 
 
trans-t-Butyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (197): 
1
H 
NMR (CDCl3,500 MHz): δ 3.44 (d, J = 11, 1H), 3.14 (dt, J = 14, 4, 1H), 2.84-2.92 (m, 
1H), 2.46-2.56 (m, 1H), 2.06-2.21 (m, 2H), 1.90-1.97 (m, 1H), 1.53 (s, 9H), 1.20-1.30 
(m, 1H), 1.08 (d, J = 6, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 163.0 (C), 83.9 (C), 
73.4 (CH), 52.0 (CH2), 34.5 (CH), 32.0 (CH2), 28.1 (CH3), 22.9 (CH2), 19.8 (CH3). 
HRMS (ESI) calcd for C11H24O4NS [M+NH4]
+
 266.1426, found 266.1383. 
 
trans-2,4-Dimethyl-3-pentyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-
carboxylate (200): 
1
H NMR (CDCl3, 500 MHz): δ 4.75 (t, J = 6, 1H), 3.60 (d, J = 11, 
1H), 3.16 (dt, J = 14, 4, 1H), 2.92 (td, J = 13, 4, 1H), 2.51-2.61 (m, 1H), 2.07- 2.23 (m, 
2H), 1.91-2.01 (m, 3H), 1.23-1.33 (m, 1H), 1.10 (d, J = 6, 3H), 0.96 (d, J = 7, 3H), 0.96 
(d, J = 7, 3H), 0.91 (t, J = 7, 6H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 164.1 (C), 86.1 
(CH), 72.9 (CH), 52.1 (CH2), 34.3 (CH), 32.1 (CH2), 29.7 (CH), 29.5 (CH), 22.8 (CH2), 
20.3 (CH3), 19.8 (CH3), 17.7 (CH3), 17.2 (CH3). HRMS (ESI) calcd for C14H30NO4S 
[M+NH4]
+
  308.1895, found 308.1877. Note: accidental equivalence of two methyls at 
19.8. 
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,3R)-3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (199): [α]D
20
 = -28.7
o
 (c 1.3, CHCl3). 
1
H NMR 
(CDCl3, 500 MHz): δ 4.84 (td, J = 11, 4.5, 1H), 3.54 (d, J = 11, 1H), 3.15 (dt, J = 14, 4, 
1H),2.90 (td, J = 14, 4, 1H), 2.50-2.60 (m, 1H), 2.08-2.23 (m, 3H), 1.92-2.01 (m, 2H), 
1.66-1.74 (m, 2H), 1.44-1.54 (m, 2H), 1.21-1.31 (m, 1H), 1.02-1.14 (m, 5H), 1.07 (d, J = 
6.5), 0.84-0.95 (m, 7H), 0.92 (d, J = 6.5), 0.91 (d, J = 6.5), 0.77 (d, J = 7, 3H). 
13
C{
1
H} 
NMR (CDCl3, 125 MHz): δ 163.5 (C), 77.4 (CH), 73.1 (CH), 52.1 (CH2), 46.9 (CH), 
40.6 (CH2), 34.4 (CH), 34.4 (CH2), 32.1 (CH2), 31.7 (CH), 26.2 (CH), 23.3 (CH2), 22.9 
(CH2), 22.1 (CH3), 21.0 (CH3), 19.8 (CH3), 16.1 (CH3). HRMS (ESI) calcd for 
C17H34NO4S [M+NH4]
+
 348.2208, found 348.2206.  
 
For entries 4 and 6 in Table 13, inseparable mixtures of 199 and its diastereomer were 
obtained. They were directly reduced to alcohol 173 for determination of the ratio. 
 
General procedure for the reduction of cyclized sulfonylacetates  
To the corresponding thiopyran-1,1-dioxide carboxylate (1 equiv.) in DCM (2.5 
mL/mmol) was added DIBALH (2.2 equiv.) and the resulting mixture stirred at rt for 12 
h. The reaction was quenched with MeOH (0.7 mL). 10%-Solution of Rochelle salt (5 
mL) was added and vigorously stirred for several hours, until solids disappeared. The 
water layer was extracted with DCM (3 × 5mL) and then EtOAc (5 mL). The combined 
organic extracts were washed with brine, dried over anhydrous Na2SO4 and concentrated 
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to afford a crude product that was purified by flash chromatography using EtOAc-
hexanes (1:4 to 1:1). 
 
trans-(3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (173): m.p. 94-95 
o
C. 
1
H NMR (CDCl3, 500 MHz): δ 4.45 (dd, J =13, 3.5, 1H), 4.00 (ddd, J = 5.5, 9, 14, 
1H), 3.11 (dt, J = 14, 3.5, 1H), 2.90-2.98 (m, 1H), 2.60 (dd, J = 11.5, 5.5, 1H), 2.50 (dd, J 
= 9, 4.5, 1H), 2.34-2.44 (m, 1H), 2.06-2.19 (m, 2H), 1.92 (dd, J = 14.5, 3, 1H), 1.28-1.37 
(m, 1H), 1.14 (d, J = 6.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 68.4 (CH), 56.2 
(CH2), 52.2 (CH2), 33.3 (CH2), 31.8 (CH), 23.1 (CH2), 19.1 (CH3). HRMS (ESI) calcd 
for C7H15O3S [M+H]
+
 179.0741, found 179.0746. 
 
(2R,3R)-(3-Methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (R,R-173), 
obtained by reduction of 199: [α]D
20
 = -16.7
o
 (c 0.5, CHCl3) 
 
(2S,3S)-(3-Methyltetrahydro-2H-thiopyran-1,1-dioxide-2-yl)methanol (S,S-173), 
obtained by reduction of S,S-194: [α]D
20
 = +14.1
o
 (c 0.4, CHCl3) 
 
Determination of enantiomeric ratio 
An oven-dried round bottom flask, equipped with a magnetic stirrer, was charged 
with DCC (1.5 equiv.), (S)-acetylmandelic acid (1.5 equiv.), and DCM (2.5 mL/mmol). 
The resulting solution was stirred at rt for 30 min, after which alcohol 173 (1 equiv.) 
dissolved in DCM (2.5 mL/mmol) was added, followed by DMAP (0.5 equiv.). The 
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reaction mixture was stirred at rt for 8 h. The reaction mixture was taken up in EtOAc (50 
mL), washed with 1N HCl solution (2 ×10 mL) and then with saturated NaHCO3. The 
organic phase was further washed with brine, dried over anhydrous Na2SO4, and 
evaporated under reduced pressure to afford the crude product, which was used for 
1
H 
NMR analysis without further purification to determine the diastereomeric ratio. The 
enantioselectivity or diastereoselectivity was measured by integration of the 
diastereomeric signals (CHCH2-O-CO, CH3-CH, Ph-CH(OAc)-CO) in 
1
H NMR spectra 
of the acetylmandalates. It was shown that chromatographic purification of the product 
can be performed without affecting the ratio determined by NMR spectroscopy. 
 
Preparation of (R)-1,4-bis(4-toluenesulfonyloxy)pentane (202) 
To the solution of (R)-pentane-1,4-diol (197, 75 mg, 0.72 mmol), prepared as 
described from L-glutamic acid, in pyridine (1.8 mL) at 0 
o
C was added p-
toluenesulfonyl chloride (345 mg, 1.80 mmol). The mixture was kept at 0 
o
C for 5 h, then 
warmed up to rt allowed to stand at this temperature for 20 h. The mixture was diluted 
with ethyl acetate, washed with 1N HCl solution, saturated aq. NaHCO3 solution, brine, 
dried over MgSO4 and concentrated under reduced pressure. The crude product was 
purified using flash chromatography to provide the pure ditosylate 198 (223 mg, 75%). 
 
(R)-1,4-Bis(4-toluenesulfonyloxy)pentane (202): [α]D
20
 = +15.1
o
 (c 2.3, CHCl3). 
1
H 
NMR (CDCl3, 500 MHz): δ 7.76 (d, J = 8.5, 2H), 7.755 (d, J = 8, 2H), 7.35 (d, J = 8.5, 
2H), 7.33 (d, J = 8.5, 2H), 4.57 (sextet, J = 6, 1H), 3.90-4.00 (m, 2H), 2.45 (s, 3H), 2.44 
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(s, 3H), 1.55-1.71 (m, 4H), 1.19 (d, J = 6, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 
145.1 (C), 144.9 (C), 134.4 (C), 133.1 (C), 130.1 (CH), 130.0 (CH), 128.0 (CH), 127.8 
(CH), 79.3 (CH), 69.3 (CH2), 32.6 (CH2), 24.6 (CH2), 21.8 (CH3), 20.9 (CH3). HRMS 
(ESI) calcd for C19H28NO6S2 [M+NH4]
+
 430.1352, found 430.1301. Note: accidental 
equivalence of two methyls at 21.8 ppm. 
 
Preparation of (R)-ethyl [4-(4-toluenesulfonyloxy)pentylsulfonyl]acetate (203) 
Ditosylate 202 (18 mg, 0.040 mmol) and ethylthioglycolate (8 mg, 0.07 mmol) 
under nitrogen were dissolved in acetone (0.1 mL), and K2CO3 (10 mg, 0.07 mmol) was 
added. The reaction mixture was stirred at rt for 18 h, the solvent was removed under 
reduced pressure, and the residue was treated with water (5 mL) and ethyl acetate (10 
mL). The layers were separated, the organic layer washed with brine, dried and 
concentrated. The crude was dissolved in CH2Cl2 (0.2 mL) and treated with m-CPBA 
(70%, 27 mg, 0.22 mmol), and left at rt for 20 h. After that time, the mixture was diluted 
with ethyl acetate, washed with NaHSO3, saturated aq. NaHCO3 solution, brine, dried 
and concentrated. Chromatography provided 199 as a yellow oil (14 mg, 82%) 
 
(R)-Ethyl [4-(4-toluenesulfonyloxy)pentylsulfonyl]acetate (203): [α]D
20
 = +14.1
o
 (c 
1.7, CHCl3). 
1
H NMR (CDCl3, 500 MHz): δ 7.80 (d, J = 8.5, 2H), 7.35 (d, J = 8.5, 2H), 
4.62-4.70 (m, 1H), 4.27 (q, J = 7, 2H), 3.92 (s, 2H), 3.19-3.26 (m, 2H), 2.45 (s, 3H), 
1.70-1.96 (m, 4H), 1.33 (t, J = 7, 3H), 1.26 (d, J = 6.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 
MHz): δ 163.2 (C), 145.1 (C), 134.3 (C), 130.1 (CH), 127.9 (CH), 79.0 (CH), 63.0 (CH2), 
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57.7 (CH2), 53.0 (CH2), 35.1 (CH2), 21.9 (CH3), 20.9 (CH3), 17.9 (CH2), 14.2 (CH3). 
HRMS (ESI) calcd for C16H28NO7S2 [M+NH4]
+
 410.1301, found 410.1315. 
 
Preparation of (2S,3S)-ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-
carboxylate (149) 
 
Sulfone 203 (35 mg, 0.089 mmol) was dissolved in DMSO (0.5 mL) under 
nitrogen atmosphere, and K2CO3 (18.5 mg, 0.134 mmol) was added. The mixture was 
vigorously stirred at rt for 24 h, then diluted with water (10 mL), and extracted with ethyl 
acetate (2 × 10 mL). The organic layer was washed with brine, dried over MgSO4 and 
concentrated. Chromatography provided 149a (12.7 g, 65%), along with the cis isomer, 
149b (5 mg, 25%). The spectral data for the compounds match previously reported.
122
 
 
 (2S,3S)-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (S,S-
149a): [α]D
20
 = +32.5
o
 (c 0.5, CHCl3). 
 
(2R,3S)-Ethyl 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (149b): 
[α]D
20
 = -36.8
o
 (c 0.3, CHCl3
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CHAPTER 4 
 SYNTHETICALLY USEFUL TRANSFORMATIONS OF CYCLIC SIX-
MEMBERED SULFONES AND SULFONATES OBTAINED BY RHODIUM-
CATALYZED INTRAMOLECULAR C–H INSERTION 
4.1 Introduction 
 Rhodium-catalyzed intramolecular C–H insertion on diazo carbonyl compounds 
has emerged as a powerful synthetic tool in the last three decades.
14, 63
 The potential of 
this reaction as a new C–C bond forming procedure, as well as its ability to streamline 
complex molecule synthesis are well documented.
42, 82, 88, 136
 As mentioned earlier, 
rhodium-catalyzed intramolecular C–H insertion on diazo carbonyl compounds occurs 
with overwhelming preference for five-membered carbocycles/heterocycles. This 
inherent preference can be overridden by factors such as substrate conformation, insertion 
site electronic effects and the reactivity of the rhodium catalyst. However, there is no 
standard procedure as to how these controlling factors can be fully explored. The 
extension of rhodium-catalyzed intramolecular C–H insertion to diazosulfones and 
diazosulfonates implicitly creates new avenues to employ C–H insertion in ways 
unattainable with diazo carbonyl compounds. 
 Jungong and co-workers
124
  have elaborated on the formation of cyclic six-
membered sulfones and sulfonates by means of rhodium-catalyzed intramolecular C–H 
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insertion. However, the chemistry of these novel cyclic six-membered compounds as 
synthetic precursors or intermediates remains largely unexplored. There is a small 
number of reports in the literature where cyclic six-membered sulfones and sulfonates 
have been converted into synthetically more relevant intermediates.
123
 Notably, Du Bois 
and co-workers
123
 have illustrated that the carbon–oxygen bond of cyclic six-membered 
ring sulfonates can be displaced with nucleophiles such as NaCN, NaN3, NaOAc, and 
thiolates to form the corresponding sulfonate salts. Even though direct extrusion of SO3 
from the resulting salts under a variety of conditions proved futile, the salts were 
successfully transformed to acyclic esters in two steps (Scheme 30).  
 
 
Scheme 30. Nucleophilic substitution reactions of δ-sultones reported by Du Bois and co-
workers.
123
 
 
 
Desulfonation of cyclic six-membered sulfonates under oxidative conditions to 
furnish five-membered lactols has also been observed by Du Bois and co-workers 
(Scheme 31).
123
 The transformation is reported to involve an oxygen transfer followed by 
a (C–S) bond cleavage to generate an α-keto ester, which is trapped internally by the 
pending hydroxyl group. 
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Scheme 31. Desulfonation of δ-sultones to form substituted lactols reported by Du Bois 
and co-workers.
123
 
 
The above examples depict six-membered cyclic sulfones and sulfonates as 
promising synthetic intermediates well-suited for complex molecule synthesis. This has 
provoked studies to explore synthetically meaningful transformations for these substrates, 
which would lead to precursors and intermediates of added value. 
 
4.2 Results and Discussion 
4.2.1 Direct Desulfonation of Cyclic Six-Membered Sulfonates (δ-
Sultones) to δ-Valerolactones via Samarium Iodide Reduction 
 For δ-sultones, it was envisioned that direct desulfonation could be achieved by 
reductive cleavage of the C–S bond which would allow a “remote alkylation” at a γ-
position relative to the hydroxyl group (Scheme 32).  
 
 
Scheme 32. Remote alkylation of alcohols leading to the formation of 5-hydroxyesters. 
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Many examples of desulfonation have been demonstrated with α-arylsulfonyl 
esters.
137-139
 However, there is no such example for α-alkoxysulfonyl substituted esters. 
Seemingly, the aryl group on the sulfur atom is essential for this reaction, as δ-sultones 
did not react in the presence of known regents for the reduction, such as Al/Hg,
140
 
Na/Hg,
141
 Mg-MeOH,
138
 and SmI2-MeOH.
137
 Desulfonation of fluoroalkylsulfonyl 
oxindoles has been attained by using SmI2 at prolonged reaction times.
139
 In this light, 
Jungong and co-workers have uncovered that SmI2 in combination with DMPU would 
react with δ-sultones to afford δ-valerolactones within three hours (Table 14).142  
 
Table 14. SmI2 reduction of δ-sultones to form δ-valerolactones reported by Jungong and 
coworkers.
142
 
 
S time P Yield (%) 
 
 
45 min 
 
 
47 
 
 
3 h 
 
 
45 
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Table 14. Cont. 
S time P Yield (%) 
 
 
3 h 
 
 
 
85 
 
 
The replacement of DMPU with the relatively more toxic HMPA yielded similar 
results. The obtained δ-valerolactones are a consequence of the cyclization of the initially 
formed 5-hydroxyesters (Scheme 33). The 5-hydroxyesters are formed from the reduction 
of δ-sultones catalyzed by SmI2/DMPU. The extrusion of SO2 from these esters followed 
by cyclization furnishes the desired lactones. Apparently, the yields for lactones 215 and 
216 are low because of the volatility of the products and a small scale of reaction. The 
reaction was found to be  sensitive to the source of SmI2, as mixed success was observed 
with commercially available SmI2. However, the reaction was high yielding and worked 
reliably with SmI2 prepared by the reaction of samarium metal with mercury iodide 
following a modification of the literature procedure for the preparation of SmCl3.
143
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Scheme 33. Mechanism for SmI2/DMPU reduction of δ-sultones to form δ-
valerolactones. 
 
4.2.2 Direct Desulfonation of Cyclic Six-Membered Sulfonates (δ-
Sultones) to γ-Butyrolactones via t-Butyl Hydroxyperoxide (TBHP) 
Oxidation 
According to literature reports,
123
 the desulfonation of sulfonates has been 
examined under oxidative conditions to form lactols. It was reasoned that α-
hydroxylation of δ-sultones would lead to the scission of the C–S bond, thereby 
permitting desulfonation and subsequent internal cyclization to 5-hydroxy-2-oxoester 
(Scheme 34). 
 
 
Scheme 34. Oxidative desulfonation of δ-sultones to 5-hydroxy-2-oxoesters. 
 
The α-hydroxylation was attained by oxidizing the corresponding enolates with 
TBHP (t-butyl hydroperoxide). While numerous bases (NaH, DBU, K2CO3, KOH, t-
 94 
 
BuOLi, TEA, and NaHMDS) effect the formation of the enolates, subsequent oxidation 
and cyclization steps were unproductive. Eventually, TBHP in combination with t-BuOK 
or KHMDS allowed the formation of γ-butyrolactones (Table 15).  
 
Table 15. TBHP oxidative desulfonation of δ-sultones to γ-butyrolactones. 
 
S conditions P Yield (%) 
 
 
TBHP, t-BuOK, rt 
 
 
93 
 
 
TBHP, t-BuOK, rt 
 
 
85 
 
 
TBHP, KHMDS, rt 
 
 
70 
 95 
 
Table 15. Cont. 
S conditions P Yield (%) 
 
 
TBHP, KHMDS, rt 
 
 
74 
 
 
Even though δ-sultone esters in the presence of t-BuOK and KHMDS both form 
enolates, the transformations were found to be  high yielding when t-BuOK was used to 
deprotonate δ-sultones derived from secondary alcohols and KHMDS for those derived 
from primary alcohols. Presumably, the reported γ-butyrolactones are obtained from the 
cyclization of the trapped 5-hydroxy-2-oxoesters (Scheme 35). Deprotonation of TBHP 
forms a t-butyl hydroperoxyl nucleophile, which reacts with the potassium enolate to 
form an alkoxide, which is eventually ring-opened, forcing the cleavage of the C–S bond 
to provide the 5-hydroxy-2-oxoester 227 that is further oxidized, presumably via a 
Baeyer-Villiger type of process, to form the mixed anhydride 233. Anhydride 233 
undegoes SO2 extrusion followed by cyclization to yield the final lactone 234. 
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Scheme 35. Mechanism of TBHP oxidative desulfonation of δ-sultones to γ-
butyrolactones. 
 
4.2.3 Alkylation of δ-Sultones and Carbethoxythiane-1,1-Dioxides 
 In general, δ-sultones and carbethoxythiane-1,1-dioxides are fairly strong C–H 
acids, which are configurationally stable in the absence of a base. Focusing on the C–H 
center adjacent to the SO2 moiety, the alkylation of these compounds with active 
electrophiles under relatively mild conditions (NaH, alkylating agent, THF, rt, 16 h) was 
observed (Table 16). Interestingly, under these conditions, it was possible to selectively 
alkylate sultone 234, although Du Bois and co-workers have demonstrated that δ-sultones 
can themselves act as electrophiles in nucleophilic substitutions. Also, high 
diastereoselectivity was witnessed in the alkylation of substrates 149a and 155.2.  
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Table 16. Alkylation of δ-sultones and carbethoxythiane-1,1-dioxides.142 
 
S X alkylating agent P Yield (%) 
 
 
CH2 
 
allyl bromide 
 
 
95 
 
 
CH2 
 
ethyl iodide 
 
 
80 
 
 
CH2 
 
tosyl azide 
 
 
90 
 
 
CH2 
 
hexachloroethane 
 
 
80 
 
 
 
 
CH2 
 
 
p-chlorobenzyl 
bromide 
 
 
81 
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Table 16. Cont. 
S X alkylating agent P  
 
 
CH2 
 
diiodomethane 
 
 
86 
 
 
O 
 
allyl bromide 
 
 
85 
 
 
CH2 
 
allyl bromide 
 
 
95 
 
 
 
 
CH2 
 
 
p-chlorobenzyl 
bromide 
 
 
95 
 
 
 
 
CH2 
 
 
p-chlorobenzyl 
bromide 
 
 
90 
 
  
 99 
 
The stereochemistry of alkylation products 244, 245 and 246 was deduced from 
NOE correlations (Figure 9). In the case of 246, the alcohol 246b, obtained after 
DIBALH reduction was used. 
 
Figure 9. Stereochemical assignment of alkylated products.
142
 
 
 It was found that the ester functionality of the δ-sultones can be selectively 
reduced by DIBALH without affecting the sultone moiety, although care must be taken as 
prolonged reaction times degrade the yield. While borane-dimethyl sulfide also proved 
effective, LAH was ineffective with both sulfones and sulfonates resulting in complete 
hydrogenolysis of the ester functionality to the methyl group. 
 Most notably, it has been uncovered that alkylated products, upon treatment with 
NaHMDS, could be rearranged by migration of the carbethoxy group in a manner similar 
to that of β-ketoesters (Scheme 36).  
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Scheme 36. Rearrangement of alkylated sulfones.
142
 
 
4.2.4 Formation of Cyclic α-Sulfonyl Oximes 
 Sulfonyl oximes constitute an important group of organic intermediates capable of 
undergoing nucleophilic substitution reactions to provide oxime ethers, which in turn lead 
to amines and carbonyl compounds.
144-146
 The synthetic potential of α-sulfonyl oximes is 
well known, however that of cyclic α-sulfonyl oximes remains limited, perhaps due to a 
little diversion within this group of compounds. A novel transformation  of 
carbethoxythiane-1,1-dioxides to the corresponding cyclic α-sulfonyl oximes under 
relatively mild conditions (isoamyl nitrite, NaH, THF) is herein reported (Table 17). For 
δ-sultones, under the same conditions, the reaction was met with complications resulting 
in a mixture of undesirable products. 
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Table 17. Formation of α-sulfonyl oximes from carbethoxythiane-1,1-dioxides. 
 
Substrate X Product Yield (%) 
 
 
CH2 
 
 
87 
 
 
CH2 
 
 
82 
 
 
CH2 
 
 
85 
 
 
CH2 
 
 
90 
 
  
The obtained cyclic α-sulfonyl oximes are formed as depicted on Scheme 37. 
Alkylation of carbethoxythiane-1,1-dioxide using NaH and isoamyl nitrite 260 results in 
the formation of sulfonyl nitrite 261. The nitite reacts with isoamyloxyl nuclophile 
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generated from the alkylation step to form 262, which undergoes rearrangement, 
followed by protonation to furnish the desired the cyclic α-sulfonyl oxime 264. 
 
 
Scheme 37. Mechanism of formation of cyclic α-sulfonyl oximes. 
 
4.3 Conclusion 
 The conversion of δ-sultones to δ-valerolactones and γ-butyrolactones has been 
demonstrated. This outlines a protocol to substituted lactones, which are common 
intermediates in the synthesis of several natural products. The stereoselective alkylation 
of δ-sultones and thiane-1,1-dioxides has also been attained. This opens possibilities for 
simple differential alkylation of thiane-1,1-dioxides, as well as construction of bicyclic 
sulfur-containing heterocyles, which could be converted to medium-sized carbocycles by 
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desulfonation. Lastly, novel cyclic α-sulfonyl oximes have been obtained from thiane-
1,1-dioxides under relatively mild conditions. The availability of these compounds would 
facilitate studies on cyclic sulfonyl oximes. In a nut shell, these findings will be 
beneficial for further studies directed at exploring the full potential of δ-sultones and 
thiane-1,1-dioxides in synthesis.  
 
4.4 Experimental Section on Synthetic Utility of Cyclic Six-Membered Sulfones and 
Sulfonates obtained by Rhodium-Catalyzed Intramolecular C–H Insertion 
 All reactions were carried out under an inert nitrogen atmosphere unless 
otherwise stated. All reagents were used as purchased without further purification except 
otherwise stated. 
1
H-NMR (500 Hz) and 
13
C{
1
H} NMR (125 Hz) spectra were recorded 
on an Avance 500 Bruker spectrometer and calibrated using residual undeuterated solvent 
as internal references. Coupling constants are given in Hz. IR spectra were recorded on a 
Perkin-Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured 
on an AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. 
HRMS data were obtained on an Agilent 61969A TOF high resolution mass spectrometer 
using electrospray ionization (ESI). Melting points were determined on a MEL-TEMP 
melting point apparatus. Analytical TLC was performed using silica gel pre-coated TLC 
plates (E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm 
silica gel (Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) 
was dried by distilling it from sodium and benzophenone in a continuous still under a 
nitrogen atmosphere. Chloroform, dichloromethane and triethylamine were distilled from 
calcium hydride under an atmosphere of nitrogen. 
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General procedure for reduction of δ-sultones with SmI2/DMPU  
To the solution of sultone (0.1 mmol) in dry THF (0.5 mL) containing DMPU (50 
mg, 0.40 mmol) was added 0.1 M solution of SmI2 (commercially available, or prepared 
by dissolving solid SmI2, obtained by reaction of samarium metal with HgI2, in dry THF) 
until the blue color persisted, and 2 mL after that (typically around 5 mL). The reaction 
mixture was stirred at rt for the specified time, after which 1N HCl solution was added (5 
mL). Hexane (30 mL) was added, and the reaction mixture was stirred for 15 min at rt. 
The layers were separated; the aqueous layer was washed with hexane (10 mL). The 
combined organic layers were washed with water (10 mL), dried over Na2SO4, and 
carefully concentrated. Flash chromatography (hexane-Et2O) provided the product. The 
obtained lactones have been previously reported. The spectral data for the obtained 
compounds match those reported in the literature, as that of the independently prepared 
authentic samples. 
 
General procedure for oxidation of δ-sultones with TBHP/t-BuOK  
To a solution of δ-sultone in THF (2.5 mL/mmol) was added t-BuOK (10 equiv.) 
or KHMDS (10 equiv.) followed by TBHP (4 equiv.).  After stirring at rt for 16 h, 
Na2SO3 was added and the resulting suspension stirred for 15 min to destroy excess 
TBHP. This was followed by the addition of 20 mL of 1N HCl solution and the resulting 
mixture taken up in Et2O, washed with brine, dried over MgSO4 and evaporated to afford 
a crude product, which was purified by flash chromatography. 
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Spectra data for 3,3,6-trimethylhexahydrobenzofuran-2-one (224) matched that in 
literature. 
 
7,8,8-Trimethyl-4-oxatricyclo[4.2.1.0
3,7
]nonan-5-one (225): colorless oil. 
1
H NMR 
(CDCl3, 500 MHz): δ 4.35 (d, 1H), 2.12-2.30 (m, 3H), 1.87 (m, 1H), 1.5 (d, J = 12.6, 
1H), 1.39 (d, J = 14.2, 1H), 1.05 (s, 3H), 0.88 (s, 3H), 0.86 (s, 3H). 
13
C{
1
H} NMR 
(CDCl3, 125 MHz): δ 181.5 (C), 87.1 (CH), 58.8 (C), 49.2 (C), 46.6 (CH), 46.3 (CH), 
36.8 (CH2), 33.4 (CH2), 20.5 (CH3), 19.4 (CH3), 11.6 (CH3).  
 
3-Methyl-3-(4-methyl-3-pentenyl)dihydrofuran-2-one (226): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz): δ 4.35 (d, 1H), 2.12-2.30 (m, 3H), 1.87 (m, 1H), 1.5 (d, J = 12.6, 
1H), 1.39 (d, J = 14.2, 1H), 1.05 (s, 3H), 0.88 (s, 3H), 0.86 (s, 3H). 
13
C{
1
H} NMR 
(CDCl3, 125 MHz): δ 181.5 (C), 87.1 (CH), 58.8 (C), 49.2 (C), 46.6 (CH), 46.3 (CH), 
36.8 (CH2), 33.4 (CH2), 20.5 (CH3), 19.4 (CH3), 11.6 (CH3).  
 
3-(3-Benzyloxypropyl)-3-ethyldihydrofuran-2-one (227):
 1
H NMR (CDCl3, 500 MHz): 
δ 7.27 (m, 5H), 4.44 (s, 2H), 3.60 (t, J = 7, 2H), 3.40 (t, J = 6.6, 2H), 1.50-1.60 (m, 2H), 
1.40-1.48 (m, 2H), 1.31-1.38 (m, 1H), 1.22-1.29 (m, 1H), 0.79 (t, J = 7, 3H). 
13
C{
1
H} 
NMR (CDCl3, 125 MHz): δ 139.0 (C), 128.7 (CH), 128.0 (CH), 127.9 (CH), 73.3 (CH2), 
71.1 (CH2), 61.6 (CH2), 36.8 (CH2), 35.3 (C), 30.1 (CH2), 29.9 (CH2), 27.2 (CH2), 26.3 
(CH2), 11.1 (CH3). 
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General procedure for alkylation of δ-sultones and thiane-1,1-dioxides 
Sodium hydride (20 mg, 60% dispersion in mineral oil, 0.5 mmol) was washed 
with THF (3 × 10 mL), and a solution of thiane-1,1-dioxide (0.2 mmol) in THF (1 mL) 
was added to it. After stirring for 15 min (when gas evolution subsided), the 
corresponding alkyl halide (allyl bromide, ethyl iodide or p-chlorobenzyl chloride, 0.4 
mmol) was added, and the reaction mixture was allowed to stir at rt for 16 h. 1N HCl 
solution (5 mL) was added, and the mixture was extracted with EtOAc (2 × 20 mL). The 
organic layer was dried with Na2SO4, and concentrated under reduced pressure. The 
product was purified by flash chromatography (hexane-EtOAc). 
 
2-Allyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 237): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz): δ 6.08-6.17 (m, 1H), 5.23 (dd, J = 17, 1.5, 1H), 5.14 (dd, J = 10, 1.5, 
1H), 4.25-4.36 (m, 2H), 3.81 (td, J = 13.5, 4, 1H), 2.97-3.04 (m, 2H), 2.82 (dd, J = 15, 7, 
1H), 2.12-2.29 (m, 2H), 1.92-1.99 (m, 1H), 1.33-1.39 (m, 4H), 1.36 (t, J = 7), 1.31 (s, 
3H), 1.00 (s, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 168.3 (C), 134.2 (CH), 118.6 
(CH2), 78.0 (C), 62.2 (CH2), 51.2 (CH2), 40.1 (C), 36.4 (CH2), 31.8 (CH2), 28.8 (CH3), 
23.0 (CH3), 19.4 (CH2), 14.2 (CH3). HRMS (ESI) calcd for C13H26NO4S (M+NH4)
+
 
292.1577, found 292.1559. 
 
2-Ethyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 238): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz):δ 4.33-4.39 (m, 1H), 4.24-4.32 (m, 1H), 3.84 (td, J = 13.5, 4, 1H), 
3.00 (dt, J = 13.5, 3.5, 1H), 2.24-3.31 (m, 1H), 2.20 (ddd, J = 14, 3.5, 3, 1H), 2.03-2.11 
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(m, 2H), 1.90-1.96 (m, 1H), 1.36 (t, J = 7.3, 3H), 1.29-1.35 (m, 1H), 1.27 (s, 3H), 1.26 (t, 
J = 7.3, 3H), 0.96 (s, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 168.4 (C), 78.7 (C), 62.0 
(CH2), 52.0 (CH2), 40.2 (C), 36.3 (CH2), 28.7 (CH3), 23.3 (CH3), 20.9 (CH2), 19.4 (CH2), 
14.3 (CH3), 11.1 (CH3). HRMS (ESI) calcd for C12H26NO4S (M+NH4)
+
 280.1577, found 
280.1577. 
 
2-Azido-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (239): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz): δ 4.37-4.51 (m, 2H), 3.51 (td, J = 13.5, 4, 1H), 3.26-3.31 (m, 1H), 
2.08-2.21 (m, 2H), 1.9 (td, J = 15, 4, 1H), 1.52-1.62 (m, 1H), 1.40 (t, J = 7.2), 1.20 (s, 
3H), 1.08 (s, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 165.3 (C), 101.0 (C), 83.9 (CH2), 
64.0 (CH2), 50.4 (CH2), 41.5 (C), 34.7 (CH3), 19.7 (CH3), 14.4 (CH3). HRMS (ESI) calcd 
for C10H25N2O4S (M+NH4)
+
 269.1283, found 293.1273. 
 
2-Chloro-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (240): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): 4.35 (q, 2H), 3.85 (td, J = 16.4, 3.4, 1H), 3.23 (dt, J = 13.5, 
3.1, 1H), 2.24-3.31 (m, 1H), 2.24-2.34 (m, 1H), 2.04-2.11 (m, 1H), 1.6 (dd, J = 12.2, 5.6, 
1H), 1.40 (s, 3H), 1.39 (t, J = 7.3, 3H), 1.10 (s, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 
165.4 (C), 92.1 (C), 64.3 (CH2), 50.3 (CH2), 43.4 (CH2), 35.4 (CH2), 27.5 (C), 24.2 
(CH3), 19.6 (CH3), 14.2 (CH3).  
 
2-(4-Chlorobenzyl)-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (241): Pale yellow 
oil. 
1
H NMR (CDCl3, 500 MHz): 7.44 (d, J = 8.1), 7.20 (d, J = 8.5), 4.28 (q, J = 7.2, 
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2H), 3.81 (td, J = 13.5, 4, 1H), 3.55 (t, J = 14.5, 2H), 3.28 (d, J = 14.5, 1H), 3.02 (dt, J = 
13, 3.2, 1H), 2.25 (qt, J = 13.8, 3.1, 1H), 2.05 (td, J = 14.1, 2.8, 1H), 1.92-1.98 (m, 1H), 
1.42 (s, 3H), 1.34 (t, J = 7.3, 3H), 1.04 (s, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 
167.6 (C), 134.4 (C), 134.2 (CH), 127.7 (CH), 79.5 (CH2), 62.2 (C), 52.3 (CH2), 40.8 
(CH3), 36.5 (CH3), 32.1 (CH2), 29.0 (CH2), 23.2 (CH3), 19.4 (CH3), 14.2 (CH3). HRMS 
(ESI) calcd for C17H24NO4SCl (M+NH4)
+
 376.1442, found 359.1083. 
 
2-Methyl-2-carbethoxy-3,3-dimethylthiane-1,1-dioxide (242): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): 4.18-4.25 (m, 2H), 3.72 (td, J = 13.2, 4.7, 1H), 2.92 (dt, J = 
13.5, 3.1, 1H), 1.98-2.12 (m, 1H), 1.82 (qd, J = 12.9, 4, 1H), 1.6 (s, 3H), 1.3 (t, J = 7.3, 
3H), 0.88 (d, J = 6.6, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 168.4 (C), 72.4 (C), 62.6 
(CH2), 49.2 (CH2), 40.9 (CH2), 29.2 (CH2), 23.3 (C), 17.5 (CH3), 14.6 (CH3), 14.5 (CH3).  
 
3-Allyl-3-carbethoxy-4,4-dimethyl-1,2-oxathiane-2,2-dioxide ( 243): Pale yellow oil. 
1
H NMR (CDCl3, 500 MHz): δ 6.05 (ddt, J = 14, 10, 7, 1H), 5.27 (dd, J = 17, 1.5, 1H), 
5.18 (dd, J = 10, 1.5, 1H), 4.72 (td, J = 12, 2, 1H), 4.44 (ddd, J = 11.5, 4.5, 2.5, 1H), 
4.29-4.38 (m, 2H), 2.86-2.96 (m, 2H), 2.61 (td, J = 13.5, 4, 1H), 1.43 (s, 3H), 1.33-1.39 
(m, 4H), 1.36 (t, J = 7), 0.99 (s, 3H). 
13
C{
1
H} NMR (CDCl3 125 MHz): δ 166.5 (C), 
133.4 (CH), 119.5 (CH2), 76.8 (C), 69.3 (CH2), 62.6 (CH2), 39.6 (CH2), 36.7 (CH2), 34.3 
(CH2), 27.8 (CH3), 23.6 (CH3), 14.2 (CH3). HRMS (ESI) calcd for C12H24NO5S 
(M+NH4)
+
 294.1369, found 294.1388. 
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(2R,3S)-2-Allyl-2-carbethoxy-3-methylthiane-1,1-dioxide (244 ): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): δ 6.10-6.19 (m, 1H), 5.20 (dq, J = 17, 1, 1H), 5.14 (d, J = 10, 
1H), 4.26-4.37 (m, 2H), 3.79 (td, J = 13.5, 4.5, 1H), 3.11 (dd, J = 15, 5.5, 1H), 2.98 (dt, J 
= 13.5, 3.5, 1H), 2.82 (dd, J = 15.5, 8.5, 1H), 2.24-2.31 (m, 1H), 2.03-2.17 (m, 2H), 1.80 
(qd, J=13, 3.5, 1H), 1.60 (dq, J = 14.5, 3.5, 1H, overlapped with water peak at 1.60 ppm), 
1.36 (t, J = 7.5, 3H), 0.99 (d, J = 6.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 167.5 
(C), 133.3 (CH), 119.0 (CH2), 75.5 (C), 62.4 (CH2), 50.7 (CH2), 39.1 (CH), 34.8 (CH2), 
29.1 (CH2), 23.0 (CH2), 17.4 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C12H21O4S 
(M+H)
+
 261.1155, found 261.1171. 
 
(2R,3S)-2-Carbethoxy-2-(4-chlorobenzyl)-3-methylthiane-1,1-dioxide ( 245): Pale 
yellow oil. 
1
H NMR (CDCl3, 500 MHz): δ 7.42 (d, J = 8, 2H), 7.22 (d, J = 8, 2H), 4.30-
4.40 (m, 2H), 3.76 (td, J = 13.5, 4, 1H), 3.66 (d, J = 14.5, 1H), 3.34 (d, J = 14.5, 1H), 
2.96 (dt, J = 14, 3.5, 1H), 2.33-2.41 (m, 1H), 2.08-2.19 (m, 1H), 2.00-2.07 (m, 1H), 1.63-
1.72 (m, 2H), 1.37 (t, J = 7, 3H), 1.07 (d, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): 
δ 167.1 (C), 134.1 (C), 133.2 (CH), 133.1 (C), 128.0 (CH), 77.2 (C), 62.6 (CH2), 51.5 
(CH2), 40.4 (CH), 35.6 (CH2), 29.6 (CH2), 22.9 (CH2), 18.1 (CH3), 14.4 (CH3). HRMS 
(ESI) calcd for C16H25NO4SCl (M+NH4)
+
 362.1187, found 362.1172. 
 
(2R,3S)-2-Carbethoxy-2-(4-chlorobenzyl)-3-methylthiolane-1,1-dioxide (246 ): Pale 
yellow oil. 
1
H NMR (CDCl3, 500 MHz): δ 7.39 (d, J = 8.5, 2H), 7.25 (d, J = 8.5, 2H), 
4.30 (qd, J = 7, 1.5, 2H), 3.44-3.52 (m, 2H), 3.27 (d, J = 14.5, 1H), 3.14-3.21 (m, 1H), 
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2.47-2.55 (m, 1H), 2.21-2.29 (m, 1H), 1.96-2.05 (m, 1H), 1.33 (t, J = 7.3, 3H), 0.90 (d, J 
= 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 166.6 (C), 133.6 (C), 133.3 (C), 132.6 
(CH), 128.5 (CH), 74.5 (C), 62.5 (CH2), 50.7 (CH2), 40.1 (CH), 35.2 (CH2), 27.0 (CH2), 
17.0 (CH3), 14.3 (CH3). HRMS (ESI) calcd for C15H23NO4SCl (M+NH4)
+
 348.1031, 
found 348.1035. 
 
DIBALH reduction of 236 and 246 
To the solution of 236 or 246 (0.1 mmol) in CH2Cl2 (0.5 mL), solution of 
DIBALH (0.5 mL, 1M in hexane, 0.5 mmol) was added at 0 
o
C. The reaction mixture 
was kept at 0 
o
C for 1h (236), or 10 h at rt (246). Concentrated aqueous solution of 
sodium potassium tartrate was added (10 mL), and the reaction mixture was stirred for 
1h. The layers were separated; the aqueous layer was washed with EtOAc (20 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated. 
Flash chromatography (hexane-EtOAc) provided the product. 
 
3-Hydroxymethyl-4,4-dimethyl-1,2-oxathiane-2,2-dioxide (236b): Obtained in 90% 
yield. Clear oil, solidified on standing. mp 62-63 
o
C. 
1
H NMR (CDCl3, 500 MHz): δ 4.66 
(td, J = 11.5, 2.5, 1H), 4.46 (dt, J = 11.5, 4, 1H), 4.20 (ddd, J = 12.5, 8, 3, 1H), 4.02-4.09 
(ddd, J = 12.5, 8, 3, 1H), 3.11 (dd, J = 8, 3, 1H), 2.41 (dd, J = 8, 3, 1H), 1.92 (ddd, J = 
14.5, 11.5 , 4, 1H), 1.61 (ddd, J = 14.5, 4, 2.5, 1H), 1.27 (s, 3H), 1.22 (s, 3H). 
13
C{
1
H} 
NMR (CDCl3, 125 MHz): δ 69.9 (CH), 69.7 (CH2), 58.3 (CH2), 38.9 (CH2), 35.8 (C), 
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29.9 (CH3), 22.1 (CH3). HRMS (ESI) calcd for C7H18NO4S (M+NH4)
+
 212.0951, found 
212.0950. 
 
(2R,3S)-4-Chlorobenzyl-2-hydroxymethyl-3-methylthiolane-1,1-dioxide (246b): 
Obtained in 94% yield. Pale yellow oil. 
1
H NMR (CDCl3, 500 MHz): δ 7.28-7.31 (m, 
4H), 3.94 (dd, J = 13, 6, 1H), 3.75 (dd, J = 13, 8, 1H), 3.42 (d, J = 14, 1H), 3.29 (ddd, J = 
13, 8.5, 3, 1H), 3.07 (ddd, J = 13, 10.5, 8.5,1H), 2.82 (d, J = 14, 1H), 2.59 (dd, J = 8, 6, 
1H), 2.31-2.39 (m, 1H), 2.13-2.21 (m, 1H), 1.90-2.00 (m, 1H), 0.85 (d, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 133.8 (C), 133.5 (C), 132.2 (CH), 128.9 (CH), 68.1 
(C), 61.3 (CH2), 51.4 (CH2), 39.5 (CH), 36.5 (CH2), 27.7 (CH2), 15.8 (CH3). HRMS 
(ESI) calcd for C13H21NO3SCl (M+NH4)
+
 306.0925, found 306.0941. 
 
Rearrangement of 237 
Compound 237 (25 mg, 0.091 mmol) was dissolved in dry THF (0.2 mL), and 
solution of NaHMDS in THF (2M in THF, 90 µL, 0.18 mmol) was added. After stirring 
at rt for 1.5 h, the reaction was quenched with 1N HCl solution (5 mL), and extracted 
with EtOAc (2 × 20 mL). The organic layer was washed with brine, dried and 
concentrated. The products were isolated using flash chromatography (EtOAc-hexane). 
The products isomerise during chromatography (verified by resubjecting pure 250a to 
chromatography). Typically, small amounts of pure 250a and 250b were isolated, along 
with a mixture of the two. 250b (the more polar isomer) was determined to be the cis 
isomer by diaxial NOE correlation between H2 and H6. Combined yield 20 mg (84%). 
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trans-2-Allyl-6-carbethoxy-3,3-dimethylthiane-1,1-dioxide (250a): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): δ 5.94-6.03 (m, 1H), 5.16 (dd, J = 17, 1.5, 1H), 5.07 (dd, J = 
10, 1.5, 1H), 4.21-4.32 (m, 2H), 3.88 (dd, J = 5, 3, 1H), 3.43 (dd, J = 7, 4, 1H), 2.78-2.87 
(m, 1H), 2.50 (ddd, J = 14, 5, 3, 1H), 2.38-2.45 (m, 1H), 2.13 (dq, J = 15, 3, 1H), 2.04 
(td, J = 14, 3, 1H), 1.39 (dt, J = 14.5, 3.5, 1H), 1.32 (t, J = 7, 3H), 1.15 (s, 3H), 1.11 (s, 
3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 167.2 (C), 136.8 (CH), 116.8 (CH2), 66.8 
(CH), 63.9 (CH), 62.4 (CH2), 37.4 (C), 34.8 (CH2), 31.0 (CH3), 26.3 (CH2), 23.4 (CH2), 
19.9 (CH3), 14.2 (CH3). HRMS (ESI) calcd for C13H23O4S (M+H)
+
 275.1311, found 
275.1320. 
 
cis-2-Allyl-6-carbethoxy-3,3-dimethylthiane-1,1-dioxide ( 250b): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): δ 5.94-6.03 (m, 1H), 5.14 (dd, J = 17, 1.5, 1H), 5.07 (dd, J = 
10, 1.5, 1H), 4.25-4.37 (m, 2H), 3.81 (dd, J = 13, 3.5, 1H), 2.83-2.91 (m, 1H), 2.82 (dd, J 
= 7, 3, 1H), 2.37-2.51 (m, 2H), 2.14 (dq, J = 15, 3, 1H), 1.68 (ddd, J = 14.5, 4.5, 3, 1H), 
1.52 (td, J = 14, 3, 1H), 1.33 (t, J = 7, 3H), 1.16 (s, 3H), 1.09 (s, 3H). 
13
C{
1
H} NMR 
(CDCl3, 125 MHz): δ 164.2 (C), 136.7 (CH), 117.1 (CH2), 71.6 (CH), 66.1 (CH), 62.8 
(CH2), 39.6 (CH2), 37.7 (C), 30.9 (CH3), 26.7 (CH2), 23.5 (CH2), 19.5 (CH3), 14.3 (CH3). 
HRMS (ESI) calcd for C13H23O4S (M+H)
+
 275.1311, found 275.1319. 
 
General Procedure for the preparation of α-sulfonyl oximes (254-257) 
 To a stirred solution of carbethoxythiane-1,1-dioxide (30-50 mg) in 2 mL of THF 
was added NaH (2 equiv.). After stirring at rt for 15 min, isoamyl nirite (2 equiv.) is 
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added and the combined mixture further stirred at room for 16 h. Upon completion as 
indicated by TLC analysis, the reaction is acidified with 1N HCl solution, extracted with 
Et2O or EtOAc, washed with brine, dried over MgSO4, filtered and the excess solvent 
removed under reduced pressure to afford a crude product that was purified by flash 
chromatography (35% EtOAc/Hexanes). 
 
2-Hydroxyimino-3-methylthiane-1,1-dioxide (254) : Pale yellow oil. 
1
H NMR (CDCl3, 
500 MHz): -3.97 (m, 1H), 3.30-3.33 (m, 1H), 3.09-3.15 (m, 1H), 2.49-
2.53 (m, 1H), 2.05-2.10 (m, 2H), 1.80-1.94 (m, 2H), 1.47 (d, J = 6.6, 3H), 
13
C{
1
H} NMR 
(CDCl3, 125 MHz): δ 160.9 (C), 54.8 (CH2), 31.1 (CH), 30.8 (CH2), 19.8 (CH2), 16.68 
(CH3).  
 
2-Hydroxyiminothiane-1,1-dioxide (255): Pale yellow oil. 
1
H NMR (CDCl3, 500 MHz):
δ 9.37 (s, 1H), 3.14 (t, J = 6, 2H), 2.97 (t, J = 6, 2H), 2.14-2.18 (m, 2H), 1.73-1.77 (m, 
2H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 158.1 (C), 55.23 (CH2), 25.6 (CH2), 25.0 
(CH2), 24.4 (CH2).  
 
2-Hydroxyimino-3-ethylthiane-1,1-dioxide (256): Pale yellow oil. 
1
H NMR (CDCl3, 
500 MHz): s, 1H), 3.72-3.73 (m, 1H), 3.41 (q, J = 7, 1H), 3.20-3.30 (m, 1H), 
3.00-3.10 (m, 1H), 2.30-2.42 (m, 1H), 1.96-2.10 (m, 2H), 1.80-1.90 (m, 1H), 1.70-1.80 
(m, 1H), 1.60 (ddd, J = 20, 14, 7, 1H), 1.18 (t, J = 7, 3H), 0.89 (t, J = 7.2, 3H). 
13
C{
1
H} 
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NMR (CDCl3, 125 MHz): δ 160.0 (C), 66.2 (CH2), 55.1 (CH2), 38.2 (CH), 29.0 (CH2), 
24.3 (CH2), 20.0 (CH2), 15.6 (CH), 12.4 (CH3).  
 
2-Hydroxyimino-3-butylthiane-1,1-dioxide (257): Pale yellow oil. 
1
H NMR (CDCl3, 
500 MHz): 32 (s, 1H), 3.84-3.85 (m, 1H), 3.20-3.33 (m, 1H), 3.10-3.14 (m, 1H), 
2.454-2.48 (m, 1H), 2.02-2.09 (m, 2H), 1.89-1.91 (m, 1H), 1.77-1.81 (m, 1H), 1.60-1.65 
(m, 5H), 0.92 (t, J = 7, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.2 (C), 55.2 (CH2), 
36.5 (CH), 30.7 (CH2), 30.0 (CH2), 29.2 (CH2), 22.8 (CH2), 20.0 (CH2), 14.3 (CH3). 
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CHAPTER 5 
 APPLICATION OF RHODIUM-CATALYZED INTRAMOLECULAR C–H 
INSERTION ON DIAZO SULFONES AND SULFONATES TOWARDS THE 
SYNTHESIS OF NATURAL PRODUCTS 
5.1 Synthesis of (+)-Bakuchiol 
5.1.1 Isolation and Biological Activity of (+)-Bakuchiol 
 (+)-Bakuchiol  is a meroterpenoid that can be found naturally in the leaves of 
Psoralea glandulosa as well as the seeds of Psoralea corylifolia.
147, 148
 Both plants 
belong to the Fabaceae family.  Psoralea glandulosa is a perennial plant common along 
the west coast of South America, especially in Peru and Chile, while Psoralea corylifolia 
is widely distributed around India and Southeastern Asia, and has been routinely used for 
Chinese and Indian medicine.  
 
 
Figure 10. Structure of (+)-bakuchiol. 
 
 The urge to synthesize (+)-bakuchiol was heightened by its broad spectrum of 
applications, ranging from treating neurodegenerative diseases, breast cancer, oral 
hygiene, plant diseases, antibacterial agent, bone strength-enhancing agent and skin care 
 116 
 
agent.
149
 There have also been several reports describing the use of (+)-bakuchiol as an 
anti-inflammatory,
150
 antioxidant,
151
 antitumor,
152
 and immunosuppressive agents.
153
  
 
5.1.2 Previous Syntheses of (+)-Bakuchiol 
 The first enantioselective total synthesis of (+)-bakuchiol was reported by Takano 
and co-workers in 1990.
154
 Since then, other syntheses have been elaborated by the 
groups of Sakakiyama,
155
 Esumi,
156
 and Du.
157
 To date, the most efficient synthesis is 
that developed by Du and co-workers, which resulted in a 51% overall yield (Scheme 
38). The synthesis was attained in 10 steps starting from geraniol. Geraniol was 
converted to epoxy silyl ether via enantioselective Sharpless epoxidation, followed by 
protection of the hydroxyl functionality with TBSCl. The Yamamoto epoxide 
rearrangement induced by methylaluminum bis[4-bromo-2,6-di(t-butyl)phenoxide] 
(MABR) provided key intermediate 269  with the desired configuration of the quaternary 
chiral center. 
 
 
Scheme 38. Construction of the quaternary chiral center by Sharpless epoxidation and 
Yamamoto rearrangement reported by Du and co-workers.
157
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5.1.3 Application of Intramolecular C–H Insertion on Diazosulfonates in 
the Synthesis of (+)-Bakuchiol 
 The structure of (+)-bakuchiol is similar to that of citronellol, which is abundantly 
present in nature. Guided by earlier studies on the formation of δ-sultones from the 
corresponding alcohols, as well as the conversion of the obtained δ-sultones into δ-
valerolactones,
122, 142
 it was envisioned that (+)-bakuchiol could be synthesized from 
commercially available citronellol by employing rhodium-catalyzed intramolecular  C–H 
insertion to install the quaternary center in the structure (Scheme 39). 
 
 
Scheme 39. Retrosynthetic disconnection for (+)-bakuchiol. 
 
 The exposure of sultone ester 207 to the SmI2/DMPU reduction conditions was 
expected to form δ-valerolactone 271. Its reduction to a diol, followed by protection of 
the hydroxyl groups and subsequent elimination would complete the synthesis of the key 
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intermediate 272, that would then be modified to the final product (+)-bakuchiol. 
Unexpectedly, the conversion of the sultone ester to the δ-valerolactone proved futile as it 
afforded a mixture of inseparable products. Even so, the peaks corresponding to the more 
substituted double bond could not be identified by 
1
H NMR – an indication that the 
double was sensitive to the reaction conditions and interfered in the reduction.  
 The enantioselective synthesis of (+)-bakuchiol was then achieved by employing 
the synthetic route outlined below (Scheme 40).
136
  Rhodium-catalyzed intramolecular 
C–H insertion was used in the synthesis of sultone ester 207. Basically, (S)-(-)-β-
citronellol was treated with ethyl (chlorosulfonyl)acetate in the presence of imidazole in 
THF. The resulting sulfonate ester was exposed to diazotransfer conditions (MsN3, DBU, 
THF, 1 h, -45 
o
C) to afford the diazosulfonate ester 141. Rhodium-catalyzed 
intramolecular C–H insertion of 141 provided 207. 
 
 
Scheme 40. Synthesis of δ-sultone 207 via rhodium-catalyzed intramolecular C–H 
insertion following procedure by Wolckenhauer and co-workers.
123
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Reduction of sultone ester 207 in the presence of DIBAL followed by mesylation 
of the resulting alcohol provided mesylates 274. Subsequent elimination followed by 
desulfonation in the presence of excess tributyltin lithium in THF resulted in alcohol 277. 
Swern oxidation of 277 completed the synthesis of key aldehyde 272.  
 
 
Scheme 41. Synthesis of aldehyde 272.
136
 
 
 To complete the synthesis, the procedure reported by Du and co-workers was 
used. Treatment of aldehyde 272 with (4-methoxybenzyl)magnesium bromide gave 
alcohol 279, which upon exposure to phosphoryl chloride in pyridine led to (+)-bakuchiol 
methyl ether 280. Conversion of 280 to (+)-bakuchiol was achieved with methyl 
magnesium iodide at elevated temperatures. 
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Scheme 42. Synthesis of (+)-bakuchiol from an aldehyde following the procedure by Du 
and co-workers.
157
 
 
5.2 Studies towards Synthesis of (+)-Quebrachamine 
5.2.1 Isolation and Biological Activity of (+)-Quebrachamine 
 (+)-Quebrachamine is an aspidosperma alkaloid, isolated from Aspidosperma 
quebracho tree back.
158
 The Aspidosperma quebracho tree, also known as white 
quebracho is common in South American countries. In general, Aspidosperma quebracho 
alkaloids (aspidospermine,
159
 yohimbine,
160
 quebrachamine,
158
 and akuammidine
161
) have 
been reported to possess diverse pharmacological properties such as hypertensive, 
spasmolytic, diuretic, peripheral vasoconstrictor, arterial hypertensive, respiratory 
stimulant, uterine sedative, and local anesthetic.
158, 162, 163
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Figure 11. Aspidosperma alkaloids isolated from the white quebracho. 
 
 
5.2.2 Previous Syntheses of Quebrachamine 
 The molecular architecture of quebrachamine encompasses a synthetically 
challenging nine-membered ring. This, alongside its attractive pharmacological potential 
has attracted considerable and sustainable interest from researchers. The first total 
synthesis for quebrachamine was reported in 1963 by Stork and co-workers.
159
 Since 
then, there have been 20 other reported syntheses for quebrachamine. To date, the most 
efficient synthesis for quebrachamine, elaborated by Bajtos and co-workers,
164
 was 
achieved in 13 linear steps and 17.8% overall yield. The synthesis entailed forming the 
indole core via a formal [3+2] dipolar cycloaddition between a functionalized nitrile and 
donor-acceptor cyclopropane, and the synthetically challenging nine-membered ring was 
prepared by an efficient chloroacetamide photocyclization (Scheme 43). 
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Scheme 43. Total synthesis of (±)-quebrachamine via [3+2] cycloaddition and efficient 
chloroacetamide photocyclization reported by Bajtos and co-workers.
164
 
 
5.2.3 Application of Rhodium-Catalyzed Intramolecular C–H Insertion on 
Diazosulfonates towards the Synthesis of (+)-Quebrachamine 
 Inspired by the findings on oxidative desulfonation of δ-sultones to γ-
butyrolactone using TBHP, it was envisioned that quebrachamine could be synthesized 
starting from commercially available 1,4-butanediol by employing the retrosynthetic 
disconnection shown on Scheme 44. Rhodium-catalyzed intramolecular C–H insertion 
will be used to implant the quaternary chiral center in the structure, followed by 
subsequent desulfonation to afford the key substituted γ-butyrolactone 227. 
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Scheme 44. Retrosynthetic analysis for the synthesis of (+)-quebrachamine. 
 
 The synthesis began with the preparation of alcohol 289, which was completed in 
five steps from commercially available 1,4-butanediol 288 (Scheme 45). Mono-
protection of the diol using silver oxide and benzyl chloride, followed by Swern 
oxidation of the resulting mono-protected alcohol led to aldehyde 292. The Horner-
Wadworth-Emmons (HWE) reaction of 292 with triethyl phosphonoacetate provided α,β-
unsaturated ester 293. Conjugate 1,4-addition of  ethylmagnesium bromide to 293 
followed by LAH reduction completed the synthesis of alcohol 289.  
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Scheme 45. Preparation of alcohol 289. 
 
 The coupling of alcohol 289 with ethyl (chlorosulfonyl)acetate in the presence of 
ImH in THF afforded sulfonate ester 295, which was subjected to diazotransfer 
conditions (nosyl azide, DIPEA, DMF, 0 
o
C). Rhodium-catalyzed intramolecular C–H 
insertion of the obtained diazosulfonate 296 gave δ-sultone ester 223. Oxidative 
desulfonation of 223 with TBHP/KHMDS resulted in the key substituted γ-butyrolactone 
227, which we intent in the future to couple with commercially available tryptamine 290. 
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Scheme 46. Preparation of substituted γ-butyrolactone 223. 
 
5.3 Studies towards Synthesis of (-)-Mesembrine 
5.3.1 Isolation and Biological Activity of (-)-Mesembrine 
 (-)-Mesembrine is the major alkaloid in Sceletium tortuosum, a groundcover plant 
native to Southern Africa.
165
 Recent studies confirm that mesembrine is an effective 
serotonin re-uptake inhibitor as well as a potent inhibitor of the enzyme 
phosphodiesterase 4 (PDE4).
166
 Mesembrine permits the brain to function with reduced 
levels of serotonin, allowing time for natural levels to build up.  
 
Figure 12. Structure of (-)-mesembrine. 
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5.3.2 Application of Rhodium-Catalyzed Intramolecular C–H Insertion on 
Diazosulfonates towards the Synthesis of (-)-Mesembrine 
 The molecular structure of (-)-mesembrine and its attractive biological properties 
have made it one of the most interesting molecules in organic synthesis. To date, there 
are over 40 total and formal syntheses of this compound. Inspite of the numerous 
syntheses of (-)-mesembrine, rhodium-catalysed intramolecular C–H insertion on 
diazosulfonates appeared to be a promising strategy that could be explored to install the 
quaternary chiral center in the structure, which upon desulfonation to a γ-butyrolactone 
would be critical to the completion of the synthesis (Scheme 47). 
 
 
Scheme 47. Retrosynthetic disconnection for (-)-mesembrine. 
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 The synthesis began with the preparation of alcohol 300, which was obtained 
from commercially available 3,4-dimethoxybenzaldehyde  301 in three linear steps. HWE 
reaction of 301 afforded α,β-unsaturated ester 302. Conjugate 1,4-addition of but-1-
enylmagnesium bromide to 302, followed by LAH reduction of the ester functionality 
completed the preparation of 300. 
 
 
Scheme 48. Preparation of alcohol 300. 
 
 Treatment of alcohol 300 with ethyl (chlorosulfonyl)acetate in the presence of 
ImH in THF afforded sulfonate ester 304, which upon exposure to diazotransfer 
condition (nosyl azide, DIPEA, DMF, 0 
o
C) led to diazosulfonate ester 305. 
Unanticipatedly, several rhodium-catalyzed C–H insertion conditions proved futile and 
the insertion is still under investigation. 
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Scheme 49. Preparation of substituted δ-sultone 299. 
 
5.4 Experimental Section on Application of Rhodium-Catalyzed Intramolecular C–H 
Insertion on Diazo Sulfones and Sulfonates towards the Synthesis of Natural Products 
All reactions were carried out under an inert nitrogen atmosphere unless otherwise stated.  
All reagents were used as purchased without further purification unless otherwise stated. 
1
H-NMR (500 Hz) and 
13
C{
1
H} NMR (125 Hz) spectra were recorded on an Avance 500 
Bruker spectrometer and calibrated using residual undeuterated solvent as internal 
references. Coupling constants are given in Hz. IR spectra were recorded on a Perkin-
Elmer Spectrum 400 Series FTIR spectrometer. Specific rotations were measured on an 
AUTOPOL III automatic polarimeter in anhydrous CHCl3 using a 10 cm cell. HRMS 
data were obtained on an Agilent 61969A TOF high resolution mass spectrometer using 
electrospray ionization (ESI). Melting points were determined on a MEL-TEMP melting 
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point apparatus. Analytical TLC was performed using silica gel pre-coated TLC plates 
(E. Merck no. 5715-7). Flash chromatography was performed using 40-63 μm silica gel 
(Merck, Geduran, no. 11567-1) as the stationary phase. Tetrahydrofuran (THF) was dried 
by distilling it from sodium and benzophenone in a continuous still under a nitrogen 
atmosphere. Chloroform, dichloromethane and triethylamine were distilled from calcium 
hydride under an atmosphere of nitrogen. 
 
Preparation of 4-(benzyloxy)butan-1-ol 291 
To a stirred solution of 1,4-butanediol (1 equiv.) in DCM was added freshly 
prepared Ag2O (1.5 equiv.) and benzyl bromide (1.1equiv.). The reaction was stirred for 
3 h and filtered through a silica gel pad. Evaporation of the solvent, followed by flash 
chromatography afforded 291. Ag2O was prepared by stirring equimolar solutions of 
AgNO3 and NaOH in water for 5 min. The resulting brown precipitate was filtered and 
dried in for 20 min in an oven. The obtained solid was cooled to room temperature, 
crushed to a fine powder and used as described. 
 
Preparation of 4-(benzyloxy)butanal 292 
DMSO (1.19 g, 15.2 mmol) was added dropwise to a solution of (COCl)2 (0.968 
g, 7.60 mmol) in CH2Cl2 (20 mL) at -78 °C. After 15 min, a solution of alcohol 291 
(0.688 g, 3.81 mmol) in CH2Cl2 (5 mL) was added dropwise to the reaction mixture at -
78 °C. After an additional 45 min, Et3N (1.53 g, 15.2 mmol) was added dropwise to the 
reaction mixture. After stirring for an additional 1 h, the reaction mixture was quenched 
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with water, extracted with CH2Cl2, washed with brine, and dried with Na2SO4. The 
solvent was removed under reduced pressure to afford crude 292. The crude product was 
purified by flash chromatography on silica gel using 3% ethyl acetate in hexanes as an 
eluent to afford 292 as colorless oil in 90% yield. 
 
Preparation of (E)-ethyl 6-(benzyloxy)hex-2-enoate 293 and (E)-ethyl [3-(3,4-
dimethoxy)phenyl]acrylate 302 
To a stirred solution of 292or 301 (1.04 g, 9.36 mmol) in DCM ( 20 mL, 2.5 
mL/mmol) was added (carbethoxymethylene)triphenylphosphorane (3.54 g, 1.1 equiv) 
and the combined reaction mixture further stirred vigorously at room temperature for 16 
h. After, the reaction mixture was evaporated to afford a crude product, which was 
purified by flash chromatography. 
 
Procedure for preparation of but-1-enylmagnesium bromide 
 An oven dried 100 mL round bottom flask equipped with a magnetic stirring bar 
and a septum was charged with LiCl (1.57 g, 37.0 mmol) and heated with a heat gun 
under high vacuum for 30 min. Magnesium turning (1.80 g, 74.0 mmol) and THF were 
added and the magnesium activated with DIBALH (70.0 µL, 0.400 mmol). After stirring 
for 5 min, the suspension was cooled to -20 
o
C and 4-bromo-1-butene (4.00 g, 29.6mol) 
added slowly, after which it was further stirred at -20 
o
C for 1h. The obtained solution 
was used for subsequent steps without purification. 
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Procedure for preparation of ethyl 6-benzyloxy-3-ethylhexanoate 294 and ethyl 3-
[(3,4-dimethoxy)phenyl]-6-heptenoate 303 
A 50 mL round bottom flask was charged with LiCl (29 mg, 0.68 mmol), CuI (65 
mg, 0.34 mmol) and THF (5.0 mL, 2.5 mL/mol), and  stirred at rt for 10 min until a pale 
yellow solution formed. The solution was cooled to 0 
o
C, 292 or 301 (850 mg, 3.41 
mmol) was added followed by TMSCl (409 mg, 3.76 mmol) and the obtained mixture 
further stirred for 15 min. A solution of EtMgBr (5.0 mL, 2.1 mmol) was added dropwise 
until the color of the solution turned violet. After stirring for 3 h, the reaction misture was 
poured onto 20 mL of saturated aqueous NH4Cl solution, extracted with ether and dried 
over MgSO4. The solvent was removed under reduced pressure and the crude product 
purified by flash chromatography. 
 
Ethyl 6-benzyloxy-3-ethylhexanoate (294): Pale yellow oil. 
1
H NMR (CDCl3, 500 
MHz): 7.3 (m, 5H), 4.40 (s, 2H), 4.02 (q, J = 7.2, 2H), 3.40 (t, J = 6.6, 2H), 2.17 (dd, J 
= 7.0, 2.2, 1H), 1.78 (q, J = 6.6, 1H), 1.58 (q, J = 6.6, 1H), 1.22-1.40 (m, 4H), 1.19 (t, J = 
7.2, 3H), 0.82 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 173.9 (C), 139.1 (C), 
129.0 (CH), 128.0 (CH), 73.3 (CH2), 71.0 (CH2), 60.6 (CH2), 39.1 (CH2), 36.7 (CH), 30.3 
(CH2), 27.3 (CH2), 26.6 (CH2), 14.8 (CH3), 11.1 (CH3).  
 
Ethyl 3-[(3,4-dimethoxy)phenyl]-6-heptenoate (303): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz):  6.76 (d, J = 8.1, 1H), 6.68 (ddd, J = 15.4, 8.1, 2.0, 2H), 5.68-5.76 
(m, 1H), 4.88-4.93 (m, 2H), 4.00 (q, J = 7.0, 2H), 3.89 (s, 3H), 3.87(s, 3H), 3.01-3.06 (m, 
1H), 2.54 (dddd, J = 14.8, 7.8, 7.2, 7.0, 2H), 1.86-1.90 (m, 2H), 1.62-1.74 (m, 2H), 1.11 
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(t, J = 7.0, 3H). 
13
C{
1
H}  NMR (CDCl3, 125 MHz): δ 172.6 (C), 149.2 (CH), 147.9 (C), 
138.5 (CH), 136.6 (C), 119.7 (CH), 115.1 (CH2), 111.5 (CH3), 111.2 (CH3), 60.5 (CH2), 
56.2 (CH), 42.3 (CH2), 41.6 (CH), 35.7 (CH2), 31.8 (CH2), 14.5 (CH3).  
 
Procedure for preparation of 6-benzyloxy-3-ethyl-1-hexanol 289 and 3-[(3,4-
dimethoxy)phenyl]-hept-6-en-1-ol 300 
A 50 mL round bottom flask charged with 294 or 303 (608 mg, 2.18 mmol) was 
stirred at 0 
o
C for 5 min followed by the addition of LAH (112 mg, 2.60 mmol). After 
stirring for 4 h, the reaction mixture was cooled to 0 
o
C and Na2SO4.10H20 (5 g) added to 
it. The resulting suspension was further stirred for 15 min, after which it was filtered and 
the residue washed several times with hot EtOAc. The combined organic extract was 
evaporated under reduced pressure to afford a crude product which was purified by flash 
chromatography.  
 
6-Benzyloxy-3-ethyl-1-hexanol (289): Pale yellow oil. 
1
H NMR (CDCl3, 500 MHz):
7.4 (m, 5H), 4.53 (s, 2H), 3.68-3.72 (m, 2H), 3.50 (t, J = 6.6, 2H), 1.60-1.70 (m, 2H), 
1.58 (q, J = 6.6, 2H), 1.28-1.48 (m, 6H), 0.84 (t, J = 7.5, 3H). 
13
C{
1
H} NMR (CDCl3, 125 
MHz): δ 139.1 (C), 129.0 (C), 128.1 (CH), 127.9 (CH), 73.4 (CH2), 71.3 (CH2), 61.8 
(CH2), 36.9 (CH2), 36.0 (CH), 30.1 (CH2), 27.3 (CH2), 26.4 (CH2), 11.1 (CH3).  
 
3-[(3,4-Dimethoxy)phenyl]-hept-6-en-1-ol (300): Pale yellow oil. 
1
H NMR (CDCl3, 500 
MHz): 6.79 (d, J = 8.1, 1H), 6.69 (ddd, J = 16, 7.8, 1.8, 2H), 5.73-5.78 (m, 1H), 4.91-
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4.95 (m, 2H), 3.88 (s, 3H), 3.86 (s, 3H), 3.44-3.54 (m, 2H), 2.66 (m, 1H), 1.62-1.80 (m, 
3H), 1.90-1.93 (m, 3H), 1.42 (s, 1H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 149.3 (CH), 
147.8 (C), 139.0 (CH), 137.7 (C), 120.0 (CH), 114.9 (CH2), 111.6 (CH3), 111.0 (CH3), 
61.5 (CH2), 56.2 (CH), 41.9 (CH2), 40.0 (CH), 36.5 (CH2), 32.0 (CH2).  
 
Preparation of ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]acetate 295 and ethyl 
[3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]acetate 304 
The necessary sulfonate esters were prepared following the procedure reported by 
Wolckenhauer and co-workers.
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Ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]acetate (295): Pale yellow oil. 
1
H NMR 
(CDCl3, 500 MHz): 7.50 (m, 5H), 4.52 (s, 2H), 4.49 (t, J = 7.0, 2H), 4.40 (q, J = 7.0, 
2H), 4.15 (s, 2H), 3.47 (t, J = 6.6, 2H), 1.74 (q, J = 7.0, 2H), 1.61 (q, J = 6.6, 2H), 1.48 
(q, J = 6.3, 2H), 1.45-1.51 (m, 6H), 1.32-1.41 (m, 3H; overlapped with triplet), 1.31 (t, J 
= 7, 3), 0.88 (t, J = 7). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 162.4 (C), 139.4 (C), 129.0 
(C), 128.1 (CH), 127.9 (CH), 73.4 (CH2), 71.3 (CH2), 70.9 (CH2), 63.2 (CH2), 55.5 
(CH2), 36.0 (CH2), 33.2 (CH), 29.7 (CH2), 27.3 (CH2), 25.9 (CH2), 14.4 (CH3), 11.1 
(CH3). 
 
Ethyl [3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]acetate (304): Pale yellow oil. 
1
H NMR (CDCl3, 500 MHz): 6.80 (d, J = 8.1, 1H), 6.68 (ddd, J = 13, 8.1, 2.2, 2H), 
5.72-5.78 (m, 1H), 4.94-4.96 (m, 2H), 4.26 (q, J = 7.2, 1H), 4.25 (ddd, J = 14, 8.5, 6.3, 
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1H), 4.00 (s, 2H), 3.91 (s, 3H), 3.88 (s, 3H), 2.68 (n, J = 5), 2H), 2.13-2.14 (m, 1H), 1.89-
1.95 (m, 3H), 1.63-1.73 (m, 2H), 1.29 (t, J = 7.2, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): 
δ 162.3 (C), 149.5 (CH), 148.1 (C), 138.6 (CH), 136.0 (C), 119.9 (CH), 115.2 (CH2), 
111.8 (CH3), 111.2 (CH3), 71.1 (CH2), 63.0 (CH2), 56.2 (CH), 55.1 (CH2), 41.2 (CH2), 
36.5 (CH2), 36.3 (CH2), 31.8 (CH2), 14.3 (CH3).  
 
Procedure for preparation of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]diazoacetate 296 and ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]diazoacetate 305 
To a solution of sulfonate 295 or 304 in DMF (2.5 mL/mmol) at 0 
o
C was added 
nosyl azide (1.1 equiv.) followed by DIPEA (2 equiv.). The temperature was maintained 
at 0 
o
C and the reaction mixture stirred for 7 h after which the reaction was complete as 
indicated by TLC analysis. The reaction mixture was then taken up in EtOAc, washed 
thrice with brine. The organic phase was dried over Na2SO4 and evaporated to give a 
crude product which was purified by flash chromatography. 
 
Ethyl [(6-benzyloxy-3-ethyl)hexyloxysulfonyl]diazoacetate (296): Pale yellow oil. 
1
H 
NMR (CDCl3, 500 MHz): 7.30 (m, 5H), 4.44 (s, 2H), 4.32 (t, J = 7.0, 2H), 4.25 (q, J = 
7.0, 2H), 3.40 (t, J = 6.6, 2H), 1.66 (q, J = 7, 2H), 1.53 (q, J = 6.6, 2H), 1.40 (q, J = 6.3, 
2H), 1.20-1.32 (m, 7H; overlapped with triplet), 0.80 (t, J = 7). 
13
C{
1
H} NMR (CDCl3, 
125 MHz): δ 160.0 (C), 139.1 (C), 129.0 (C), 128.1 (CH), 73.4 (CH2), 72.7 (CH2), 71.2 
(CH2), 63.2 (CH2), 35.8 (CH2), 32.9 (CH), 29.7 (CH2), 27.3 (CH2), 25.9 (CH2), 14.9 
(CH3), 11.1 (CH3).  
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Ethyl [3-(3,4-dimethoxy)phenyl-6-heptenyloxysulfonyl]diazoacetate (305): Pale 
yellow oil. 
1
H NMR (CDCl3, 500 MHz): 6.81 (d, J = 8.1, 1H), 6.70 (ddd, J = 13, 8.1, 
1.8, 2H), 5.73-5.78 (m, 1H), 4.93-4.97 (m, 2H), 4.32 (q, J = 7.2), 4.25 (ddd, J = 15, 8.8, 
5.6), 3.91 (s, 3H), 3.87 (s, 3H), 2.70 (n, J = 5.0), 2H), 2.12-2.17 (m, 1H), 1.88-1.94 (m, 
3H), 1.66-1.74 (m, 2H), 1.30 (t, J = 7.2), 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 159.7 
(C), 149.5 (CH), 148.1 (C), 138.6 (CH), 135.9 (C), 119.9 (CH), 115.2 (CH2), 111.7 
(CH3), 111.1 (CH3), 72.1 (CH2), 63.0 (CH2), 56.3 (CH), 56.2 (CH), 55.1 (CH2), 41.2 
(CH2), 36.3 (CH2), 31.8 (CH2), 14.6 (CH3).  
 
Preparation of 3-carbethoxy-4-(3-benzyloxy)propyl-4-ethyl-1,2-oxathiane-2,2-
dioxide 223 
 
 To a suspension of Rh2esp2 catalyst (1 mol%) in CH2Cl2 (4 mL/mmol), a solution 
of 296 (1 equiv.) in CH2Cl2 (2 mL/mmol) was added at rt over a period of 1 h using a 
syringe pump. Upon completion of the addition, the reaction mixture was stirred at rt for 
additional 8 h. All volatiles were removed under reduced pressure. The crude reaction 
mixture was separated on silica column (ethyl acetate–hexanes, 30%). 
 
3-Carbethoxy-4-(3-benzyloxy)propyl-4-ethyl-1,2-oxathiane-2,2-dioxide (223): Pale 
yellow oil. 
1
H NMR (CDCl3, 500 MHz): 7.30-7.40 (m, 5H), 4.64-4.67 (m, 2H), 4.49-
4.55 (m, 2H), 4.52 (s, 2H; overlapped with multiplet), 4.48 (s, 2H), 3.93 (d, J = 4.7, 2H), 
3.41 (t, J = 6.6, 2H), 3.43-3.58 (m, 2H), 3.28-3.42 (m, 2H), 1.88-1.20 (q, J = 6.6, 2H), 
1.40-1.64 (q, J = 6.3, 2H), 1.22-1.38 (m, 7H; overlapped with triplet), 0.84-0.94 (t, J = 
7.0, 3H). 
13
C{
1
H} NMR (CDCl3, 125 MHz): δ 160.0 (C), 139.1 (C), 129.0 (C), 128.1 
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(CH), 73.4 (CH2), 72.7 (CH2), 71.2 (CH2), 63.2 (CH2), 35.8 (CH2), 32.9 (CH), 29.7 
(CH2), 27.3 (CH2), 25.9 (CH2), 14.9 (CH3), 11.1 (CH3).  
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APENDIX I: LIST OF ABBREVIATIONS AND ACRONYMS 
1,2-DCE 
 
1,2-dichloroethane 
acam 
 
acetamide 
Ac acetate 
B3LYP  Becke, 3-parameter, Lee-Yang-Parr 
BARF  tetra-aryl borate 
Bn  benzyl 
Bu  butyl 
cap  caprolactam 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC  N,N'-dicyclohexylcarbodiimide 
DCM  dichloromethane 
DEPT  distortionless enhancement by polarization transfer 
DIBAL-H  diisobutylaluminum hydride 
DIPEA  N,N-diisopropylethylamine 
DMAP 
 
dimethylaminopyridine 
DMPU N,N'-dimethylpropyleneurea 
DMF  N,N-dimethylformamide 
DMSO  dimethyl sulfoxide 
DOSP  N-(p-dodecylphenylsulfonyl)prolinate 
DPT 
 
diisopropyltartrate 
EDG 
 
electron-donating group 
EWG electron-withdrawing group 
er  enantiomeric ratio 
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Et  ethyl 
esp  α, α, ά, ά-tetramethyl-1,3-benzenedipropionate 
FDA  food and drug administration 
HMPA  hexamethylphosphoramide 
HRMS  high resolution mass spectrometry 
HWE  Horner-Wadsworth-Emmons 
Hz  hertz 
ImH  imidazole 
HMDS  hexamethyldisilazane 
LAH  lithium aluminum hydride 
LDA 
 
lithium diisopropylamide 
MABR 
 
methylaluminum bis[4-bromo-2,6-di(tert-butyl)phenoxide] 
m-CPBA meta-chloroperoxybenzoic acid 
MEPY  methyl 2-pyrrolidone-5-carboxylate 
MEOX  methyl 2-oxazolidone-4-carboxylate 
MPPIM  
methyl (3-phenylpropanoyl) imidazolidin-2-one-4 
carboxylate 
Ms 
 
mesyl 
NMR nuclear magnetic resonance 
NOE  nuclear overhauser effect 
Nos  nosyl 
nta  N-naphthaloyl alanate 
ntpa  N-naphthaloyl phenylalanate 
nttl  N-naphthaloyl tert-butylalanate 
oct  octaoate 
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OTF  trifluoromethanesulfonate 
pfb  perfluorobutyrate 
ptad  N-phthaloyl adamantyl leucinate 
ptpa  N-phthaloyl phenyl leucinate 
pttl  N-phthaloyl-tert-leucinate 
Py  pyridine 
rt  room temperature 
SN1  unimolecular nucleophilic substitution 
SN2  bimolecular nucleophilic substitution 
TBHP  tert-butyl hydroxyperoxide 
TBDPS  tert-butyldiphenylsilyl 
TBDPS  tert-butyldiphenylsilyl 
TBS 
 
tert-butyldimethylsilyl  
TEA triethylamine 
tfa 
 
trifluoroacetate 
THF tetrahydrofuran 
TIPS  triisopropylsilyl  
TLC  thin layer chromatography 
TMS  tetramethylsilane 
TMS 
 
trimethylsilyl  
tpa triphenyl acetate 
TPAP  tetrapropylammonium perruthenate 
Tol  tolyl 
Ts 
 
p-toluenesulfonyl 
TS transition state 
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APENDIX II: SELECTED SPECTRA, FIGURES 13–150 
 
Figure 13. 
1
H NMR (500 MHz) spectrum of ethyl (propylsulfonyl)acetate (155.1) in 
CDCl3. 
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Figure 14. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (propylsulfonyl)acetate (155.1) in 
CDCl3. 
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Figure 15. 
1
H NMR (500 MHz) spectrum of ethyl (2-methylpropylsulfonyl)acetate 
(156.1) in CDCl3. 
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Figure 16. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (2-methylpropylsulfonyl)acetate 
(156.1) in CDCl3. 
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Figure 17. DEPT 135 NMR (125 MHz) spectrum of ethyl (2-
methylpropylsulfonyl)acetate (156.1) in CDCl3. 
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Figure 18. 
1
H NMR (500 MHz) spectrum of ethyl (3-methylbutylsulfonyl)acetate (160.1) 
in CDCl3. 
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Figure 19. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (3-methylbutylsulfonyl)acetate 
(160.1) in CDCl3. 
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Figure 20. 
1
H NMR (500 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate (158.2) in 
CDCl3. 
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Figure 21. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate 
(158.2) in CDCl3. 
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Figure 22. DEPT 135 NMR (125 MHz) spectrum of ethyl (propylsulfonyl)diazoacetate 
(158.2) in CDCl3. 
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Figure 23. 
1
H NMR (500 MHz) spectrum of ethyl (2-methylpropylsulfonyl)diazoacetate 
(159.2) in CDCl3. 
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Figure 24. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (2-
methylpropylsulfonyl)diazoacetate (159.2) in CDCl3. 
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Figure 25. DEPT 135 NMR (125 MHz) spectrum of ethyl (2-
methylpropylsulfonyl)diazoacetate (159.2) in CDCl3. 
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Figure 26. 
1
H NMR (500 MHz) spectrum of ethyl (3-methylbutylsulfonyl)diazoacetate 
(160.2) in CDCl3. 
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Figure 27. 
13
C{
1
H} NMR (500 MHz) spectrum of ethyl (3-
methylbutylsulfonyl)diazoacetate (160.2) in CDCl3. 
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Figure 28. DEPT 135 NMR (500 MHz) spectrum of ethyl (3-
methylbutylsulfonyl)diazoacetate (160.2) in CDCl3. 
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Figure 29. 
1
H NMR (500 MHz) spectrum of ethyl (2-methyl-2-propenylsulfonyl)acetate 
(161) in CDCl3. 
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Figure 30. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (2-methyl-2-
propenylsulfonyl)acetate (161) in CDCl3. 
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Figure 31. DEPT 135 NMR (125 MHz) spectrum of ethyl (2-methyl-2-
propenylsulfonyl)acetate (161) in CDCl3. 
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Figure 32. 
1
H NMR (500 MHz) spectrum of ethyl (3,3-dimethylthiotane-1,1-dioxide-2-
carboxylate (159.2.2) in CDCl3. 
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Figure 33. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl (3,3-dimethylthiotane-1,1-
dioxide-2-carboxylate (159.2.2) in CDCl3. 
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Figure 34. DEPT 135 NMR (125 MHz) spectrum of ethyl 3,3-dimethylthiotane-1,1-
dioxide-2-carboxylate (159.2.2) in CDCl3. 
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   Figure 35. 
1
H NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3-
dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3. 
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Figure 36. 
13
C{
1
H} NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3-
dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3. 
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Figure 37. DEPT 135 NMR (500 MHz) spectrum of ethyl tetrahydro-2-ethyl-3,3-
dimethylthiophene-1,1-dioxide-2-carboxylate (160.2.2) in CDCl3. 
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Figure 38. 
1
H NMR (500 MHz) spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3. 
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Figure 39. 
13
C{
1
H} NMR spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3. 
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Figure 40. DEPT-135 NMR spectrum of (pentylsulfonyl)acetic acid (182) in CDCl3. 
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Figure 41. 
1
H NMR (500 MHz) spectrum of methyl (pentylsulfonyl)acetate (183) in 
CDCl3. 
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Figure 42. 
13
C{
1
H} NMR (125 MHz) spectrum of methyl (pentylsulfonyl)acetate (183) in 
CDCl3. 
 171 
 
 
Figure 43. DEPT 135 NMR (125 MHz) spectrum of methyl (pentylsulfonyl)acetate (183) 
in CDCl3. 
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Figure 44. 
1
H NMR (500 MHz) spectrum of isopropyl (pentylsulfonyl)acetate (184) in 
CDCl3. 
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Figure 45. 
13
C{
1
H} NMR (125MHz) spectrum of isopropyl (pentylsulfonyl)acetate (184) 
in CDCl3. 
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Figure 46. DEPT 135 NMR (125MHz) spectrum of isopropyl (pentylsulfonyl)acetate 
(184) in CDCl3. 
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Figure 47. 
1
H NMR (500 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185) in 
CDCl3. 
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Figure 48. 
13
C{
1
H} NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185) in 
CDCl3. 
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Figure 49. DEPT 135 NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)acetate (185) 
in CDCl3. 
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Figure 50. 
1
H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 
(pentylsulfonyl)acetate (187) in CDCl3. 
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Figure 51. 
13
C{
1
H} NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl (pentylsulfonyl)acetate (187) in CDCl3. 
 
 180 
 
 
 
Figure 52. DEPT 135 NMR (500 MHz) spectrum of (1R,2S,5R)-2-Isopropyl-5-
methylcyclohexyl (pentylsulfonyl)acetate (187) in CDCl3. 
 181 
 
 
 
Figure 53. 
1
H NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)acetate (188) in CDCl3. 
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Figure 54. 
13
C{
1
H} NMR (125 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)acetate (188) in CDCl3. 
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Figure 55. DEPT 135 NMR (125 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)acetate (188) in CDCl3. 
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Figure 56. 
1
H NMR (500 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate (189) in 
CDCl3. 
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Figure 57. 
13
C{
1
H} NMR (125 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate 
(189) in CDCl3. 
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Figure 58. DEPT 135 NMR (125 MHz) spectrum of methyl (pentylsulfonyl)diazoacetate 
(189) in CDCl3. 
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Figure 59. 
1
H NMR (500 MHz) spectrum of isopropyl (pentylsulfonyl)diazoacetate (190) 
in CDCl3. 
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Figure 60. 
13
C{
1
H} NMR (125 MHz) spectrum of isopropyl (pentylsulfonyl)diazoacetate 
(190) in CDCl3. 
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Figure 61. DEPT 135 NMR (125 MHz) spectrum of isopropyl 
(pentylsulfonyl)diazoacetate (190) in CDCl3. 
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Figure 62. 
1
H NMR (500 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate (191) in 
CDCl3. 
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Figure 63. 
13
C{
1
H} NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate 
(191) in CDCl3. 
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Figure 64. DEPT 135 NMR (125 MHz) spectrum of t-butyl (pentylsulfonyl)diazoacetate 
(191) in CDCl3. 
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Figure 65. 
1
H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 
(pentylsulfonyl)diazoacetate (193) in CDCl3. 
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Figure 66. 
13
C{
1
H} NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl (pentylsulfonyl)diazoacetate (193) in CDCl3. 
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Figure 67. DEPT 135 NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl (pentylsulfonyl)diazoacetate (193) in CDCl3. 
 196 
 
 
 
Figure 68. 
1
H NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)diazoacetate (194) in CDCl3. 
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Figure 69. 
13
C{
1
H} NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)diazoacetate (194) in CDCl3. 
 198 
 
 
 
Figure 70. DEPT 135 NMR (500 MHz) spectrum of 2,4-dimethyl-3-pentyl 
(pentylsulfonyl)diazoacetate (194) in CDCl3. 
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Figure 71. 
1
H NMR (500 MHz) spectrum of trans-methyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3. 
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Figure 72. 
13
C{
1
H} NMR (125 MHz) spectrum of trans-methyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3. 
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Figure 73. DEPT 135 NMR (125 MHz) spectrum of trans-methyl 3-methyltetrahydro-
2H-thiopyran-1,1-dioxide-2-carboxylate (195) in CDCl3. 
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Figure 74. 
1
H NMR (500 MHz) spectrum of trans-isopropyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3. 
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Figure 75. 
13
C{
1
H} NMR (125MHz) spectrum of trans-isopropyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3. 
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Figure 76. DEPT 135 NMR (125MHz) spectrum of trans-isopropyl 3-methyltetrahydro-
2H-thiopyran-1,1-dioxide-2-carboxylate (196) in CDCl3. 
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Figure 77. 
1
H NMR (500 MHz) spectrum of trans-t-butyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3. 
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Figure 78. 
13
C{
1
H} NMR (125 MHz) spectrum of trans-t-butyl 3-methyltetrahydro-2H-
thiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3. 
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Figure 79. DEPT 135 NMR (125 MHz) spectrum of trans-t-butyl 3-methyltetrahydro-
2H-thiopyran-1,1-dioxide-2-carboxylate (197) in CDCl3. 
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Figure 80. 
1
H NMR (500 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 
(2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (199) in CDCl3 
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Figure 81. 
13
C{
1
H} NMR (125 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl (2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate 
(199) in CDCl3. 
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Figure 82. DEPT 135 NMR (125 MHz) spectrum of (1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl (2R,3R) 3-methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate 
(199) in CDCl3. 
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Figure 83. 
1
H NMR (500 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3-
methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3. 
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Figure 84. 
13
C{
1
H} NMR (125 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3-
methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3. 
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Figure 85. DEPT 135 NMR (125 MHz) spectrum of trans-2,4-dimethyl-3-pentyl 3-
methyltetrahydro-2H-thiopyran-1,1-dioxide-2-carboxylate (200) in CDCl3. 
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Figure 86. 
1
H NMR (500 MHz) spectrum of (R)-1,4-bis(4-toluenesulfonyloxy)pentane 
(202) in CDCl3. 
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Figure 87. 
13
C{
1
H} NMR (125 MHz) spectrum of (R)-1,4-bis(4-
toluenesulfonyloxy)pentane (202) in CDCl3. 
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Figure 88. DEPT 135 NMR (125 MHz) spectrum of (R)-1,4-bis(4-
toluenesulfonyloxy)pentane (202) in CDCl3. 
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Figure 89. 
1
H NMR (500 MHz) spectrum of (R)-ethyl [4-(4-
toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3. 
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Figure 90. 
13
C{
1
H} NMR (125 MHz) spectrum of (R)-ethyl [4-(4-
toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3. 
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Figure 91. DEPT 135 NMR (125 MHz) spectrum of (R)-ethyl [4-(4-
toluenesulfonyloxy)pentylsulfonyl]acetate (203) in CDCl3. 
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Figure 92. 
1
H NMR (500 MHz) spectrum of 7,8,8-trimethyl-4-
oxatricyclo[4.2.1.0
3,7
]nonan-5-one (225) in CDCl3. 
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Figure 93. 
13
C{
1
H} NMR (125 MHz) spectrum of 7,8,8-trimethyl-4-
oxatricyclo[4.2.1.0
3,7
]nonan-5-one (225) in CDCl3. 
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Figure 94. DEPT-135 NMR (125 MHz) spectrum of 7,8,8-trimethyl-4-
oxatricyclo[4.2.1.0
3,7
]nonan-5-one (225) in CDCl3 
 223 
 
 
 
 
Figure 95. 
1
H NMR (500 MHz) spectrum of 3-methyl-3-(4-methyl-3-
pentenyl)dihydrofuran-2-one (226) in CDCl3. 
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Figure 96. 
13
C{
1
H} NMR (125 MHz) spectrum of 3-methyl-3-(4-methyl-3-
pentenyl)dihydrofuran-2-one (226) in CDCl3. 
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Figure 97. 
1
H NMR (500 MHz) spectrum of 3-(3-benzyloxypropyl)-3-ethyldihydrofuran-
2-one (227) in CDCl3. 
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Figure 98. 
13
C{
1
H} NMR (125 MHz) spectrum of 3-(3-benzyloxypropyl)-3-
ethyldihydrofuran-2-one (227) in CDCl3. 
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Figure 99. DEPT 135 NMR (125 MHz) spectrum of 3-(3-benzyloxypropyl)-3-
ethyldihydrofuran-2-one (227) in CDCl3. 
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Figure 100. 
1
H NMR (500 MHz) spectrum of 2-azido-2-carbethoxy-3,3-dimethylthiane-
1,1-dioxide (239) in CDCl3. 
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Figure 101. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-azido-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (239) in CDCl3. 
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Figure 102. DEPT 135 NMR (125 MHz) spectrum of 2-azido-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (239) in CDCl3. 
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Figure 103. 
1
H NMR (500 MHz) spectrum of 2-chloro-2-carbethoxy-3,3-dimethylthiane-
1,1-dioxide (240) in CDCl3. 
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Figure 104. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-chloro-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (240) in CDCl3. 
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Figure 105. DEPT 135 NMR (125 MHz) spectrum of 2-chloro-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (240) in CDCl3. 
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Figure 106. 
1
H NMR (500 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (241) in CDCl3. 
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Figure 107. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (241) in CDCl3. 
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Figure 108. DEPT 135 NMR (125 MHz) spectrum of 2-(4-chlorobenzyl)-2-carbethoxy-
3,3-dimethylthiane-1,1-dioxide (241) in CDCl3. 
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Figure 109. 
1
H NMR (500 MHz) spectrum of 2-methyl-2-carbethoxy-3,3-dimethylthiane-
1,1-dioxide (242) in CDCl3. 
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Figure 110. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-methyl-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (242) in CDCl3. 
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Figure 111. DEPT 135 NMR (125 MHz) spectrum of 2-methyl-2-carbethoxy-3,3-
dimethylthiane-1,1-dioxide (242) in CDCl3. 
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Figure 112. 
1
H NMR (500 MHz) spectrum of 2-hydroxyimino-3-methylthiane-1,1-
dioxide (254) in CDCl3. 
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Figure 113. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-methylthiane-1,1-
dioxide (254) in CDCl3. 
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Figure 114. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-methylthiane-
1,1-dioxide (254) in CDCl3. 
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Figure 115. 
1
H NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide (255) in 
CDCl3. 
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Figure 116. 
13
C{
1
H} NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide 
(255) in CDCl3. 
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Figure 117. DEPT 135 NMR (500 MHz) spectrum of 2-hydroxyiminothiane-1,1- dioxide 
(255) in CDCl3. 
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Figure 118. 
1
H NMR (500 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1-dioxide 
(256) in CDCl3. 
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Figure 119. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1-
dioxide (256) in CDCl3. 
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Figure 120. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-ethylthiane-1,1-
dioxide (256) in CDCl3. 
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Figure 121. 
1
H NMR (500 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1-dioxide 
(257) in CDCl3. 
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Figure 122. 
13
C{
1
H} NMR (125 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1-
dioxide (257) in CDCl3. 
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Figure 123. DEPT 135 NMR (125 MHz) spectrum of 2-hydroxyimino-3-butylthiane-1,1-
dioxide (257) in CDCl3. 
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Figure 124. 
1
H NMR (500 MHz) spectrum of ethyl 6-benzyloxy-3-ethylhexanoate (294) 
in CDCl3. 
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Figure 125. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl 6-benzyloxy-3-ethylhexanoate 
(294) in CDCl3. 
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Figure 126. DEPT 135 NMR (125 MHz) spectrum of ethyl 6-benzyloxy-3-
ethylhexanoate (294) in CDCl3. 
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Figure 127. 
1
H NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol (289) in 
CDCl3. 
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Figure 128. 
13
C{
1
H} NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol (589) 
in CDCl3. 
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Figure 129.  DEPT 135 NMR (500 MHz) spectrum of 6-benzyloxy-3-ethyl-1-hexanol 
(289) in CDCl3. 
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Figure 130. 
1
H NMR (500 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]acetate (295) in CDCl3. 
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Figure 131. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]acetate (295) in CDCl3. 
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Figure 132. DEPT 135 NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]acetate (295) in CDCl3. 
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Figure 133. 
1
H NMR (500 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3. 
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Figure 134. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3. 
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Figure 135. DEPT 135 NMR (125 MHz) spectrum of ethyl [(6-benzyloxy-3-
ethyl)hexyloxysulfonyl]diazoacetate (296) in CDCl3. 
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Figure 136. 
1
H NMR (500 MHz) spectrum of 3-carbethoxy-4-(3-benzyloxy)propyl-4-
ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3. 
 265 
 
 
 
 
Figure 137. 
13
C{
1
H} NMR (500 MHz) spectrum of 3-carbethoxy-4-(3-benzyloxy)propyl-
4-ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3. 
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Figure 138. DEPT 135 NMR (500 MHz) spectrum of 3-carbethoxy-4-(3-
benzyloxy)propyl-4-ethyl-1,2- oxathiane-2,2-dioxide (223) in CDCl3. 
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Figure 139. 
1
H NMR (500 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6-
heptenoate (303) in CDCl3. 
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Figure 140. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6-
heptenoate (303) in CDCl3. 
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Figure 141. DEPT 135 NMR (125 MHz) spectrum of ethyl 3-(3,4-dimethoxy)phenyl-6-
heptenoate (303) in CDCl3. 
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Figure 142. 
1
H NMR (500 MHz) spectrum of 3-(3,4-dimethoxy)phenyl-hept-6-en-1-ol 
(300) in CDCl3. 
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Figure 143. 
13
C{
1
H} NMR (125 MHz) spectrum of 3-(3,4-dimethoxy)phenylhept-6-en-1-
ol (300) in CDCl3. 
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Figure 144. DEPT 135 NMR (125 MHz) spectrum of 3-(3,4-dimethoxy)phenylhept-6-en-
1-ol (300) in CDCl3. 
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Figure 145. 
1
H NMR (500 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]acetate (304) in CDCl3. 
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Figure 146. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]acetate (304) in CDCl3. 
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Figure 147. DEPT 135 NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]acetate (304) in CDCl3. 
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Figure 148. 
1
H NMR (500 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]diazoacetate (305) in CDCl3. 
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Figure 149. 
13
C{
1
H} NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]diazoacetate (305) in CDCl3. 
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Figure 150. DEPT 135 NMR (125 MHz) spectrum of ethyl [3-(3,4-dimethoxy)phenyl-6-
heptenyloxysulfonyl]diazoacetate (305) in CDCl3. 
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